id	sid	tid	token	lemma	pos
ajlm-23	1	1	article	article	PROPN
ajlm-23	1	2	information	information	NOUN
ajlm-23	1	3	authors	author	NOUN
ajlm-23	1	4	:	:	PUNCT
ajlm-23	2	1	philip	philip	PROPN
ajlm-23	2	2	h.	h.	PROPN
ajlm-23	2	3	fortgens1,2	fortgens1,2	PROPN
ajlm-23	2	4	fierdoz	fierdoz	VERB
ajlm-23	2	5	omar1,2	omar1,2	ADJ
ajlm-23	2	6	affiliations	affiliation	NOUN
ajlm-23	2	7	:	:	PUNCT
ajlm-23	2	8	1department	1department	NUM
ajlm-23	2	9	of	of	ADP
ajlm-23	2	10	clinical	clinical	ADJ
ajlm-23	2	11	laboratory	laboratory	NOUN
ajlm-23	2	12	sciences	science	NOUN
ajlm-23	2	13	,	,	PUNCT
ajlm-23	2	14	division	division	NOUN
ajlm-23	2	15	of	of	ADP
ajlm-23	2	16	chemical	chemical	ADJ
ajlm-23	2	17	pathology	pathology	PROPN
ajlm-23	2	18	,	,	PUNCT
ajlm-23	2	19	university	university	PROPN
ajlm-23	2	20	of	of	ADP
ajlm-23	2	21	cape	cape	NOUN
ajlm-23	2	22	town	town	NOUN
ajlm-23	2	23	,	,	PUNCT
ajlm-23	2	24	south	south	ADJ
ajlm-23	2	25	africa2national	africa2national	ADJ
ajlm-23	2	26	health	health	NOUN
ajlm-23	2	27	laboratory	laboratory	NOUN
ajlm-23	2	28	service	service	NOUN
ajlm-23	2	29	,	,	PUNCT
ajlm-23	2	30	groote	groote	PROPN
ajlm-23	2	31	schuur	schuur	PROPN
ajlm-23	2	32	hospital	hospital	PROPN
ajlm-23	2	33	,	,	PUNCT
ajlm-23	2	34	south	south	PROPN
ajlm-23	2	35	africa	africa	PROPN
ajlm-23	2	36	correspondence	correspondence	NOUN
ajlm-23	2	37	to	to	ADP
ajlm-23	2	38	:	:	PUNCT
ajlm-23	2	39	philip	philip	PROPN
ajlm-23	2	40	fortgens	fortgens	PROPN
ajlm-23	2	41	postal	postal	ADJ
ajlm-23	2	42	address	address	NOUN
ajlm-23	2	43	:	:	PUNCT
ajlm-23	2	44	division	division	NOUN
ajlm-23	2	45	of	of	ADP
ajlm-23	2	46	chemical	chemical	ADJ
ajlm-23	2	47	pathology	pathology	PROPN
ajlm-23	2	48	,	,	PUNCT
ajlm-23	2	49	university	university	PROPN
ajlm-23	2	50	of	of	ADP
ajlm-23	2	51	cape	cape	PROPN
ajlm-23	2	52	town	town	NOUN
ajlm-23	2	53	/	/	SYM
ajlm-23	2	54	national	national	PROPN
ajlm-23	2	55	health	health	PROPN
ajlm-23	2	56	laboratory	laboratory	PROPN
ajlm-23	2	57	service	service	PROPN
ajlm-23	2	58	,	,	PUNCT
ajlm-23	2	59	groote	groote	PROPN
ajlm-23	2	60	schuur	schuur	PROPN
ajlm-23	2	61	hospital	hospital	PROPN
ajlm-23	2	62	,	,	PUNCT
ajlm-23	2	63	anzio	anzio	PROPN
ajlm-23	2	64	road	road	NOUN
ajlm-23	2	65	,	,	PUNCT
ajlm-23	2	66	observatory	observatory	ADJ
ajlm-23	2	67	,	,	PUNCT
ajlm-23	2	68	cape	cape	NOUN
ajlm-23	2	69	town	town	NOUN
ajlm-23	2	70	,	,	PUNCT
ajlm-23	2	71	7925	7925	NUM
ajlm-23	2	72	dates	date	NOUN
ajlm-23	2	73	:	:	PUNCT
ajlm-23	2	74	received	receive	VERB
ajlm-23	2	75	:	:	PUNCT
ajlm-23	2	76	09	09	NUM
ajlm-23	2	77	dec	dec	PROPN
ajlm-23	2	78	.	.	PROPN
ajlm-23	2	79	2011	2011	NUM
ajlm-23	2	80	accepted	accept	VERB
ajlm-23	2	81	:	:	PUNCT
ajlm-23	2	82	20	20	NUM
ajlm-23	2	83	sep	sep	NOUN
ajlm-23	2	84	.	.	PROPN
ajlm-23	3	1	2013	2013	NUM
ajlm-23	3	2	published	publish	VERB
ajlm-23	3	3	:	:	PUNCT
ajlm-23	3	4	03	03	NUM
ajlm-23	3	5	dec	dec	PROPN
ajlm-23	3	6	.	.	PROPN
ajlm-23	3	7	2013	2013	NUM
ajlm-23	3	8	how	how	SCONJ
ajlm-23	3	9	to	to	PART
ajlm-23	3	10	cite	cite	VERB
ajlm-23	3	11	this	this	DET
ajlm-23	3	12	article	article	NOUN
ajlm-23	3	13	:	:	PUNCT
ajlm-23	3	14	fortgens	fortgens	PROPN
ajlm-23	3	15	ph	ph	PROPN
ajlm-23	3	16	,	,	PUNCT
ajlm-23	3	17	omar	omar	PROPN
ajlm-23	3	18	f.	f.	PROPN
ajlm-23	3	19	cardiac	cardiac	PROPN
ajlm-23	3	20	troponin	troponin	PROPN
ajlm-23	3	21	t	t	PROPN
ajlm-23	3	22	quantitative	quantitative	ADJ
ajlm-23	3	23	assay	assay	NOUN
ajlm-23	3	24	failure	failure	NOUN
ajlm-23	3	25	as	as	ADP
ajlm-23	3	26	a	a	DET
ajlm-23	3	27	result	result	NOUN
ajlm-23	3	28	of	of	ADP
ajlm-23	3	29	antibody	antibody	NOUN
ajlm-23	3	30	interference	interference	NOUN
ajlm-23	3	31	.	.	PUNCT
ajlm-23	4	1	afr	afr	PROPN
ajlm-23	4	2	j	j	PROPN
ajlm-23	4	3	lab	lab	PROPN
ajlm-23	4	4	med	med	PROPN
ajlm-23	4	5	.	.	PUNCT
ajlm-23	4	6	2013;2(1	2013;2(1	NUM
ajlm-23	4	7	)	)	PUNCT
ajlm-23	4	8	,	,	PUNCT
ajlm-23	4	9	art	art	NOUN
ajlm-23	4	10	.	.	PUNCT
ajlm-23	5	1	#	#	SYM
ajlm-23	5	2	23	23	NUM
ajlm-23	5	3	,	,	PUNCT
ajlm-23	5	4	3	3	NUM
ajlm-23	5	5	pages	page	NOUN
ajlm-23	5	6	.	.	PUNCT
ajlm-23	6	1	http://dx.doi.org/10.4102/	http://dx.doi.org/10.4102/	NUM
ajlm-23	6	2	ajlm.v2i1.23	ajlm.v2i1.23	ADJ
ajlm-23	6	3	copyright	copyright	NOUN
ajlm-23	6	4	notice	notice	NOUN
ajlm-23	6	5	:	:	PUNCT
ajlm-23	6	6	©	©	PROPN
ajlm-23	6	7	2013	2013	NUM
ajlm-23	6	8	.	.	PUNCT
ajlm-23	7	1	the	the	DET
ajlm-23	7	2	authors	author	NOUN
ajlm-23	7	3	.	.	PUNCT
ajlm-23	8	1	licensee	licensee	NOUN
ajlm-23	8	2	:	:	PUNCT
ajlm-23	8	3	aosis	aosis	NOUN
ajlm-23	8	4	openjournals	openjournal	NOUN
ajlm-23	8	5	.	.	PUNCT
ajlm-23	9	1	this	this	PRON
ajlm-23	9	2	is	be	AUX
ajlm-23	9	3	an	an	DET
ajlm-23	9	4	open	open	ADJ
ajlm-23	9	5	access	access	NOUN
ajlm-23	9	6	article	article	NOUN
ajlm-23	9	7	distributed	distribute	VERB
ajlm-23	9	8	under	under	ADP
ajlm-23	9	9	the	the	DET
ajlm-23	9	10	terms	term	NOUN
ajlm-23	9	11	of	of	ADP
ajlm-23	9	12	the	the	DET
ajlm-23	9	13	creative	creative	ADJ
ajlm-23	9	14	commons	common	NOUN
ajlm-23	9	15	attribution	attribution	NOUN
ajlm-23	9	16	license	license	NOUN
ajlm-23	9	17	,	,	PUNCT
ajlm-23	9	18	which	which	PRON
ajlm-23	9	19	permits	permit	VERB
ajlm-23	9	20	unrestricted	unrestricted	ADJ
ajlm-23	9	21	use	use	NOUN
ajlm-23	9	22	,	,	PUNCT
ajlm-23	9	23	distribution	distribution	NOUN
ajlm-23	9	24	,	,	PUNCT
ajlm-23	9	25	and	and	CCONJ
ajlm-23	9	26	reproduction	reproduction	NOUN
ajlm-23	9	27	in	in	ADP
ajlm-23	9	28	any	any	DET
ajlm-23	9	29	medium	medium	NOUN
ajlm-23	9	30	,	,	PUNCT
ajlm-23	9	31	provided	provide	VERB
ajlm-23	9	32	the	the	DET
ajlm-23	9	33	original	original	ADJ
ajlm-23	9	34	work	work	NOUN
ajlm-23	9	35	is	be	AUX
ajlm-23	9	36	properly	properly	ADV
ajlm-23	9	37	cited	cite	VERB
ajlm-23	9	38	.	.	PUNCT
ajlm-23	10	1	cardiac	cardiac	ADJ
ajlm-23	10	2	troponin	troponin	PROPN
ajlm-23	10	3	t	t	PROPN
ajlm-23	10	4	quantitative	quantitative	ADJ
ajlm-23	10	5	assay	assay	NOUN
ajlm-23	10	6	failure	failure	NOUN
ajlm-23	10	7	as	as	ADP
ajlm-23	10	8	a	a	DET
ajlm-23	10	9	result	result	NOUN
ajlm-23	10	10	of	of	ADP
ajlm-23	10	11	antibody	antibody	NOUN
ajlm-23	10	12	interference	interference	NOUN
ajlm-23	10	13	in	in	ADP
ajlm-23	10	14	this	this	DET
ajlm-23	10	15	oorspronklike	oorspronklike	NOUN
ajlm-23	10	16	navorsing	navorsing	NOUN
ajlm-23	10	17	:	:	PUNCT
ajlm-23	10	18	wiskundeonderrig	wiskundeonderrig	NOUN
ajlm-23	10	19	...	...	PUNCT
ajlm-23	10	20	open	open	ADJ
ajlm-23	10	21	access	access	NOUN
ajlm-23	10	22	•	•	ADP
ajlm-23	10	23	abstract	abstract	ADJ
ajlm-23	10	24	•	•	NUM
ajlm-23	10	25	introduction	introduction	NOUN
ajlm-23	10	26	•	•	NUM
ajlm-23	10	27	research	research	NOUN
ajlm-23	10	28	method	method	NOUN
ajlm-23	10	29	and	and	CCONJ
ajlm-23	10	30	design	design	NOUN
ajlm-23	10	31	   	   	SPACE
ajlm-23	10	32	•	•	NOUN
ajlm-23	10	33	case	case	NOUN
ajlm-23	10	34	   	   	SPACE
ajlm-23	10	35	•	•	NOUN
ajlm-23	10	36	interference	interference	NOUN
ajlm-23	10	37	experiments	experiment	NOUN
ajlm-23	10	38	•	•	NUM
ajlm-23	10	39	results	result	NOUN
ajlm-23	10	40	•	•	NOUN
ajlm-23	10	41	discussion	discussion	NOUN
ajlm-23	10	42	•	•	NOUN
ajlm-23	10	43	conclusion	conclusion	NOUN
ajlm-23	10	44	•	•	NUM
ajlm-23	10	45	acknowledgements	acknowledgement	NOUN
ajlm-23	10	46	   	   	SPACE
ajlm-23	10	47	•	•	NOUN
ajlm-23	10	48	competing	compete	VERB
ajlm-23	10	49	interest	interest	NOUN
ajlm-23	10	50	   	   	SPACE
ajlm-23	10	51	•	•	NUM
ajlm-23	10	52	authors	author	NOUN
ajlm-23	10	53	’	'	PUNCT
ajlm-23	10	54	contributions	contribution	NOUN
ajlm-23	10	55	•	•	NUM
ajlm-23	10	56	references	reference	NOUN
ajlm-23	10	57	abstract	abstract	ADJ
ajlm-23	10	58	top	top	PROPN
ajlm-23	10	59	↑	↑	PROPN
ajlm-23	10	60	background	background	NOUN
ajlm-23	10	61	:	:	PUNCT
ajlm-23	10	62	immunoassays	immunoassay	NOUN
ajlm-23	10	63	are	be	AUX
ajlm-23	10	64	prone	prone	ADJ
ajlm-23	10	65	to	to	PART
ajlm-23	10	66	interference	interference	VERB
ajlm-23	10	67	by	by	ADP
ajlm-23	10	68	various	various	ADJ
ajlm-23	10	69	substances	substance	NOUN
ajlm-23	10	70	which	which	PRON
ajlm-23	10	71	may	may	AUX
ajlm-23	10	72	cause	cause	VERB
ajlm-23	10	73	inaccurate	inaccurate	ADJ
ajlm-23	10	74	results	result	NOUN
ajlm-23	10	75	.	.	PUNCT
ajlm-23	11	1	this	this	DET
ajlm-23	11	2	type	type	NOUN
ajlm-23	11	3	of	of	ADP
ajlm-23	11	4	interference	interference	NOUN
ajlm-23	11	5	is	be	AUX
ajlm-23	11	6	difficult	difficult	ADJ
ajlm-23	11	7	to	to	PART
ajlm-23	11	8	detect	detect	VERB
ajlm-23	11	9	analytically.objective	analytically.objective	ADP
ajlm-23	11	10	:	:	PUNCT
ajlm-23	11	11	a	a	DET
ajlm-23	11	12	case	case	NOUN
ajlm-23	11	13	of	of	ADP
ajlm-23	11	14	cardiac	cardiac	ADJ
ajlm-23	11	15	troponin	troponin	PROPN
ajlm-23	11	16	t	t	PROPN
ajlm-23	11	17	quantitative	quantitative	ADJ
ajlm-23	11	18	reader	reader	NOUN
ajlm-23	11	19	(	(	PUNCT
ajlm-23	11	20	roche	roche	NOUN
ajlm-23	11	21	diagnostics	diagnostic	NOUN
ajlm-23	11	22	)	)	PUNCT
ajlm-23	11	23	assay	assay	NOUN
ajlm-23	11	24	failure	failure	NOUN
ajlm-23	11	25	was	be	AUX
ajlm-23	11	26	detected	detect	VERB
ajlm-23	11	27	and	and	CCONJ
ajlm-23	11	28	investigated	investigate	VERB
ajlm-23	11	29	in	in	ADP
ajlm-23	11	30	order	order	NOUN
ajlm-23	11	31	to	to	PART
ajlm-23	11	32	ascertain	ascertain	VERB
ajlm-23	11	33	the	the	DET
ajlm-23	11	34	likely	likely	ADJ
ajlm-23	11	35	cause	cause	NOUN
ajlm-23	11	36	.	.	PUNCT
ajlm-23	12	1	method	method	NOUN
ajlm-23	12	2	:	:	PUNCT
ajlm-23	12	3	patient	patient	ADJ
ajlm-23	12	4	whole	whole	ADJ
ajlm-23	12	5	blood	blood	NOUN
ajlm-23	12	6	was	be	AUX
ajlm-23	12	7	mixed	mix	VERB
ajlm-23	12	8	with	with	ADP
ajlm-23	12	9	cardiac	cardiac	ADJ
ajlm-23	12	10	troponin	troponin	ADJ
ajlm-23	12	11	t	t	PROPN
ajlm-23	12	12	-	-	PUNCT
ajlm-23	12	13	positive	positive	ADJ
ajlm-23	12	14	blood	blood	NOUN
ajlm-23	12	15	,	,	PUNCT
ajlm-23	12	16	patient	patient	NOUN
ajlm-23	12	17	and	and	CCONJ
ajlm-23	12	18	control	control	NOUN
ajlm-23	12	19	sera	sera	NOUN
ajlm-23	12	20	were	be	AUX
ajlm-23	12	21	denuded	denude	VERB
ajlm-23	12	22	of	of	ADP
ajlm-23	12	23	immunoglobulin	immunoglobulin	NOUN
ajlm-23	12	24	g	g	NOUN
ajlm-23	12	25	by	by	ADP
ajlm-23	12	26	protein	protein	NOUN
ajlm-23	12	27	a	a	DET
ajlm-23	12	28	-	-	PUNCT
ajlm-23	12	29	affinity	affinity	NOUN
ajlm-23	12	30	chromatography	chromatography	NOUN
ajlm-23	12	31	and	and	CCONJ
ajlm-23	12	32	patient	patient	ADJ
ajlm-23	12	33	sera	sera	NOUN
ajlm-23	12	34	were	be	AUX
ajlm-23	12	35	mixed	mix	VERB
ajlm-23	12	36	with	with	ADP
ajlm-23	12	37	mouse	mouse	NOUN
ajlm-23	12	38	serum	serum	NOUN
ajlm-23	12	39	.	.	PUNCT
ajlm-23	13	1	samples	sample	NOUN
ajlm-23	13	2	were	be	AUX
ajlm-23	13	3	analysed	analyse	VERB
ajlm-23	13	4	on	on	ADP
ajlm-23	13	5	a	a	DET
ajlm-23	13	6	cardiac	cardiac	ADJ
ajlm-23	13	7	troponin	troponin	PROPN
ajlm-23	13	8	t	t	PROPN
ajlm-23	13	9	quantitative	quantitative	ADJ
ajlm-23	13	10	reader	reader	NOUN
ajlm-23	13	11	.	.	PUNCT
ajlm-23	14	1	results	result	NOUN
ajlm-23	14	2	:	:	PUNCT
ajlm-23	14	3	a	a	DET
ajlm-23	14	4	mixture	mixture	NOUN
ajlm-23	14	5	of	of	ADP
ajlm-23	14	6	patient	patient	ADJ
ajlm-23	14	7	whole	whole	ADJ
ajlm-23	14	8	blood	blood	NOUN
ajlm-23	14	9	and	and	CCONJ
ajlm-23	14	10	cardiac	cardiac	ADJ
ajlm-23	14	11	troponin	troponin	PROPN
ajlm-23	14	12	t	t	PROPN
ajlm-23	14	13	-	-	PUNCT
ajlm-23	14	14	positive	positive	ADJ
ajlm-23	14	15	blood	blood	NOUN
ajlm-23	14	16	resulted	result	VERB
ajlm-23	14	17	in	in	ADP
ajlm-23	14	18	assay	assay	ADJ
ajlm-23	14	19	failure	failure	NOUN
ajlm-23	14	20	;	;	PUNCT
ajlm-23	14	21	removal	removal	NOUN
ajlm-23	14	22	of	of	ADP
ajlm-23	14	23	immunoglobulin	immunoglobulin	NOUN
ajlm-23	14	24	g	g	NOUN
ajlm-23	14	25	from	from	ADP
ajlm-23	14	26	patient	patient	ADJ
ajlm-23	14	27	sera	sera	NOUN
ajlm-23	14	28	reversed	reverse	VERB
ajlm-23	14	29	the	the	DET
ajlm-23	14	30	cardiac	cardiac	ADJ
ajlm-23	14	31	troponin	troponin	PROPN
ajlm-23	14	32	t	t	PROPN
ajlm-23	14	33	assay	assay	NOUN
ajlm-23	14	34	failure	failure	NOUN
ajlm-23	14	35	;	;	PUNCT
ajlm-23	14	36	the	the	DET
ajlm-23	14	37	addition	addition	NOUN
ajlm-23	14	38	of	of	ADP
ajlm-23	14	39	mouse	mouse	NOUN
ajlm-23	14	40	serum	serum	NOUN
ajlm-23	14	41	as	as	ADP
ajlm-23	14	42	a	a	DET
ajlm-23	14	43	heterophile	heterophile	NOUN
ajlm-23	14	44	antibody	antibody	NOUN
ajlm-23	14	45	blocking	block	VERB
ajlm-23	14	46	agent	agent	NOUN
ajlm-23	14	47	had	have	VERB
ajlm-23	14	48	no	no	DET
ajlm-23	14	49	effect	effect	NOUN
ajlm-23	14	50	.	.	PUNCT
ajlm-23	15	1	conclusion	conclusion	NOUN
ajlm-23	15	2	:	:	PUNCT
ajlm-23	15	3	it	it	PRON
ajlm-23	15	4	is	be	AUX
ajlm-23	15	5	proposed	propose	VERB
ajlm-23	15	6	that	that	SCONJ
ajlm-23	15	7	the	the	DET
ajlm-23	15	8	interference	interference	NOUN
ajlm-23	15	9	resulting	result	VERB
ajlm-23	15	10	in	in	ADP
ajlm-23	15	11	assay	assay	ADJ
ajlm-23	15	12	failure	failure	NOUN
ajlm-23	15	13	may	may	AUX
ajlm-23	15	14	not	not	PART
ajlm-23	15	15	be	be	AUX
ajlm-23	15	16	because	because	SCONJ
ajlm-23	15	17	of	of	ADP
ajlm-23	15	18	a	a	DET
ajlm-23	15	19	heterophile	heterophile	ADJ
ajlm-23	15	20	antibody	antibody	NOUN
ajlm-23	15	21	,	,	PUNCT
ajlm-23	15	22	but	but	CCONJ
ajlm-23	15	23	rather	rather	ADV
ajlm-23	15	24	a	a	DET
ajlm-23	15	25	result	result	NOUN
ajlm-23	15	26	of	of	ADP
ajlm-23	15	27	a	a	DET
ajlm-23	15	28	circulating	circulate	VERB
ajlm-23	15	29	autoantibody	autoantibody	NOUN
ajlm-23	15	30	to	to	ADP
ajlm-23	15	31	cardiac	cardiac	ADJ
ajlm-23	15	32	troponin	troponin	PROPN
ajlm-23	15	33	t	t	PROPN
ajlm-23	15	34	,	,	PUNCT
ajlm-23	15	35	which	which	PRON
ajlm-23	15	36	may	may	AUX
ajlm-23	15	37	compete	compete	VERB
ajlm-23	15	38	with	with	ADP
ajlm-23	15	39	antibody	antibody	NOUN
ajlm-23	15	40	assay	assay	NOUN
ajlm-23	15	41	reagents	reagent	NOUN
ajlm-23	15	42	for	for	ADP
ajlm-23	15	43	binding	bind	VERB
ajlm-23	15	44	sites	site	NOUN
ajlm-23	15	45	.	.	PUNCT
ajlm-23	16	1	introduction	introduction	NOUN
ajlm-23	16	2	top	top	PROPN
ajlm-23	16	3	↑	↑	PROPN
ajlm-23	16	4	a	a	DET
ajlm-23	16	5	consensus	consensus	NOUN
ajlm-23	16	6	document	document	NOUN
ajlm-23	16	7	released	release	VERB
ajlm-23	16	8	by	by	ADP
ajlm-23	16	9	the	the	DET
ajlm-23	16	10	european	european	PROPN
ajlm-23	16	11	society	society	PROPN
ajlm-23	16	12	of	of	ADP
ajlm-23	16	13	cardiology	cardiology	NOUN
ajlm-23	16	14	,	,	PUNCT
ajlm-23	16	15	the	the	DET
ajlm-23	16	16	american	american	PROPN
ajlm-23	16	17	college	college	PROPN
ajlm-23	16	18	of	of	ADP
ajlm-23	16	19	cardiology	cardiology	NOUN
ajlm-23	16	20	,	,	PUNCT
ajlm-23	16	21	the	the	DET
ajlm-23	16	22	american	american	ADJ
ajlm-23	16	23	heart	heart	PROPN
ajlm-23	16	24	association	association	PROPN
ajlm-23	16	25	and	and	CCONJ
ajlm-23	16	26	the	the	DET
ajlm-23	16	27	world	world	NOUN
ajlm-23	16	28	heart	heart	PROPN
ajlm-23	16	29	federation	federation	PROPN
ajlm-23	16	30	task	task	PROPN
ajlm-23	16	31	force	force	NOUN
ajlm-23	16	32	in	in	ADP
ajlm-23	16	33	2012	2012	NUM
ajlm-23	16	34	has	have	AUX
ajlm-23	16	35	proposed	propose	VERB
ajlm-23	16	36	cardiac	cardiac	ADJ
ajlm-23	16	37	troponin	troponin	ADJ
ajlm-23	16	38	(	(	PUNCT
ajlm-23	16	39	ctn	ctn	NOUN
ajlm-23	16	40	)	)	PUNCT
ajlm-23	16	41	as	as	ADP
ajlm-23	16	42	the	the	DET
ajlm-23	16	43	preferred	preferred	ADJ
ajlm-23	16	44	biomarker	biomarker	NOUN
ajlm-23	16	45	for	for	ADP
ajlm-23	16	46	myocardial	myocardial	ADJ
ajlm-23	16	47	necrosis	necrosis	NOUN
ajlm-23	16	48	because	because	SCONJ
ajlm-23	16	49	of	of	ADP
ajlm-23	16	50	its	its	PRON
ajlm-23	16	51	superlative	superlative	ADJ
ajlm-23	16	52	myocardial	myocardial	ADJ
ajlm-23	16	53	tissue	tissue	NOUN
ajlm-23	16	54	specificity	specificity	NOUN
ajlm-23	16	55	and	and	CCONJ
ajlm-23	16	56	high	high	ADJ
ajlm-23	16	57	clinical	clinical	ADJ
ajlm-23	16	58	sensitivity.1	sensitivity.1	PROPN
ajlm-23	16	59	furthermore	furthermore	ADV
ajlm-23	16	60	,	,	PUNCT
ajlm-23	16	61	ctn	ctn	NOUN
ajlm-23	16	62	has	have	AUX
ajlm-23	16	63	also	also	ADV
ajlm-23	16	64	been	be	AUX
ajlm-23	16	65	shown	show	VERB
ajlm-23	16	66	to	to	PART
ajlm-23	16	67	have	have	VERB
ajlm-23	16	68	value	value	NOUN
ajlm-23	16	69	for	for	ADP
ajlm-23	16	70	the	the	DET
ajlm-23	16	71	prediction	prediction	NOUN
ajlm-23	16	72	of	of	ADP
ajlm-23	16	73	adverse	adverse	ADJ
ajlm-23	16	74	cardiovascular	cardiovascular	ADJ
ajlm-23	16	75	events	event	NOUN
ajlm-23	16	76	in	in	ADP
ajlm-23	16	77	patients	patient	NOUN
ajlm-23	16	78	presenting	present	VERB
ajlm-23	16	79	with	with	ADP
ajlm-23	16	80	acute	acute	ADJ
ajlm-23	16	81	coronary	coronary	ADJ
ajlm-23	16	82	syndrome.2	syndrome.2	PROPN
ajlm-23	16	83	cardiac	cardiac	PROPN
ajlm-23	16	84	troponin	troponin	PROPN
ajlm-23	16	85	t	t	PROPN
ajlm-23	16	86	(	(	PUNCT
ajlm-23	16	87	ctnt	ctnt	PROPN
ajlm-23	16	88	)	)	PUNCT
ajlm-23	16	89	appears	appear	VERB
ajlm-23	16	90	to	to	PART
ajlm-23	16	91	be	be	AUX
ajlm-23	16	92	an	an	DET
ajlm-23	16	93	important	important	ADJ
ajlm-23	16	94	marker	marker	NOUN
ajlm-23	16	95	of	of	ADP
ajlm-23	16	96	coronary	coronary	ADJ
ajlm-23	16	97	heart	heart	NOUN
ajlm-23	16	98	disease	disease	NOUN
ajlm-23	16	99	,	,	PUNCT
ajlm-23	16	100	mortality	mortality	NOUN
ajlm-23	16	101	and	and	CCONJ
ajlm-23	16	102	risk	risk	NOUN
ajlm-23	16	103	of	of	ADP
ajlm-23	16	104	heart	heart	NOUN
ajlm-23	16	105	failure	failure	NOUN
ajlm-23	16	106	in	in	ADP
ajlm-23	16	107	a	a	DET
ajlm-23	16	108	healthy	healthy	ADJ
ajlm-23	16	109	population	population	NOUN
ajlm-23	16	110	without	without	ADP
ajlm-23	16	111	manifest	manif	ADJ
ajlm-23	16	112	cardiovascular	cardiovascular	ADJ
ajlm-23	16	113	disease.3measurement	disease.3measurement	NOUN
ajlm-23	16	114	of	of	ADP
ajlm-23	16	115	cardiac	cardiac	ADJ
ajlm-23	16	116	troponins	troponin	NOUN
ajlm-23	16	117	is	be	AUX
ajlm-23	16	118	achieved	achieve	VERB
ajlm-23	16	119	by	by	ADP
ajlm-23	16	120	immunoassay	immunoassay	PROPN
ajlm-23	16	121	.	.	PUNCT
ajlm-23	17	1	despite	despite	SCONJ
ajlm-23	17	2	extensive	extensive	ADJ
ajlm-23	17	3	experience	experience	NOUN
ajlm-23	17	4	with	with	ADP
ajlm-23	17	5	this	this	DET
ajlm-23	17	6	methodology	methodology	NOUN
ajlm-23	17	7	,	,	PUNCT
ajlm-23	17	8	however	however	ADV
ajlm-23	17	9	,	,	PUNCT
ajlm-23	17	10	immunoassays	immunoassay	NOUN
ajlm-23	17	11	are	be	AUX
ajlm-23	17	12	occasionally	occasionally	ADV
ajlm-23	17	13	subject	subject	ADJ
ajlm-23	17	14	to	to	ADP
ajlm-23	17	15	interfering	interfere	VERB
ajlm-23	17	16	substances	substance	NOUN
ajlm-23	17	17	that	that	PRON
ajlm-23	17	18	compromise	compromise	VERB
ajlm-23	17	19	their	their	PRON
ajlm-23	17	20	accuracy	accuracy	NOUN
ajlm-23	17	21	–	–	PUNCT
ajlm-23	17	22	indeed	indeed	ADV
ajlm-23	17	23	,	,	PUNCT
ajlm-23	17	24	it	it	PRON
ajlm-23	17	25	is	be	AUX
ajlm-23	17	26	estimated	estimate	VERB
ajlm-23	17	27	that	that	SCONJ
ajlm-23	17	28	antibody	antibody	NOUN
ajlm-23	17	29	interference	interference	NOUN
ajlm-23	17	30	affects	affect	VERB
ajlm-23	17	31	approximately	approximately	ADV
ajlm-23	17	32	one	one	NUM
ajlm-23	17	33	in	in	ADP
ajlm-23	17	34	2000	2000	NUM
ajlm-23	17	35	immunoassay	immunoassay	NOUN
ajlm-23	17	36	results.4	results.4	PROPN
ajlm-23	17	37	we	we	PRON
ajlm-23	17	38	report	report	VERB
ajlm-23	17	39	a	a	DET
ajlm-23	17	40	novel	novel	ADJ
ajlm-23	17	41	case	case	NOUN
ajlm-23	17	42	of	of	ADP
ajlm-23	17	43	assay	assay	ADJ
ajlm-23	17	44	failure	failure	NOUN
ajlm-23	17	45	using	use	VERB
ajlm-23	17	46	the	the	DET
ajlm-23	17	47	cardiac	cardiac	ADJ
ajlm-23	17	48	troponin	troponin	PROPN
ajlm-23	17	49	t	t	PROPN
ajlm-23	17	50	quantitative	quantitative	ADJ
ajlm-23	17	51	reader	reader	NOUN
ajlm-23	17	52	(	(	PUNCT
ajlm-23	17	53	roche	roche	NOUN
ajlm-23	17	54	diagnostics	diagnostic	NOUN
ajlm-23	17	55	)	)	PUNCT
ajlm-23	17	56	.	.	PUNCT
ajlm-23	18	1	research	research	NOUN
ajlm-23	18	2	method	method	NOUN
ajlm-23	18	3	and	and	CCONJ
ajlm-23	18	4	design	design	VERB
ajlm-23	18	5	top	top	ADJ
ajlm-23	18	6	↑	↑	PROPN
ajlm-23	18	7	case	case	NOUN
ajlm-23	18	8	a	a	DET
ajlm-23	18	9	61	61	NUM
ajlm-23	18	10	-	-	PUNCT
ajlm-23	18	11	year	year	NOUN
ajlm-23	18	12	-	-	PUNCT
ajlm-23	18	13	old	old	ADJ
ajlm-23	18	14	female	female	NOUN
ajlm-23	18	15	,	,	PUNCT
ajlm-23	18	16	with	with	ADP
ajlm-23	18	17	a	a	DET
ajlm-23	18	18	history	history	NOUN
ajlm-23	18	19	of	of	ADP
ajlm-23	18	20	ischaemic	ischaemic	ADJ
ajlm-23	18	21	heart	heart	NOUN
ajlm-23	18	22	disease	disease	NOUN
ajlm-23	18	23	and	and	CCONJ
ajlm-23	18	24	hypertension	hypertension	NOUN
ajlm-23	18	25	,	,	PUNCT
ajlm-23	18	26	presented	present	VERB
ajlm-23	18	27	to	to	ADP
ajlm-23	18	28	the	the	DET
ajlm-23	18	29	emergency	emergency	NOUN
ajlm-23	18	30	unit	unit	NOUN
ajlm-23	18	31	on	on	ADP
ajlm-23	18	32	two	two	NUM
ajlm-23	18	33	occasions	occasion	NOUN
ajlm-23	18	34	12	12	NUM
ajlm-23	18	35	days	day	NOUN
ajlm-23	18	36	apart	apart	ADV
ajlm-23	18	37	with	with	ADP
ajlm-23	18	38	chest	chest	NOUN
ajlm-23	18	39	discomfort	discomfort	NOUN
ajlm-23	18	40	.	.	PUNCT
ajlm-23	19	1	repeated	repeat	VERB
ajlm-23	19	2	attempts	attempt	NOUN
ajlm-23	19	3	by	by	ADP
ajlm-23	19	4	the	the	DET
ajlm-23	19	5	diagnostic	diagnostic	ADJ
ajlm-23	19	6	laboratory	laboratory	NOUN
ajlm-23	19	7	to	to	PART
ajlm-23	19	8	obtain	obtain	VERB
ajlm-23	19	9	ctnt	ctnt	ADJ
ajlm-23	19	10	measurements	measurement	NOUN
ajlm-23	19	11	failed	fail	VERB
ajlm-23	19	12	,	,	PUNCT
ajlm-23	19	13	as	as	SCONJ
ajlm-23	19	14	reflected	reflect	VERB
ajlm-23	19	15	by	by	ADP
ajlm-23	19	16	the	the	DET
ajlm-23	19	17	absence	absence	NOUN
ajlm-23	19	18	of	of	ADP
ajlm-23	19	19	a	a	DET
ajlm-23	19	20	positive	positive	ADJ
ajlm-23	19	21	control	control	NOUN
ajlm-23	19	22	line	line	NOUN
ajlm-23	19	23	on	on	ADP
ajlm-23	19	24	test	test	NOUN
ajlm-23	19	25	strips	strip	NOUN
ajlm-23	19	26	(	(	PUNCT
ajlm-23	19	27	cardiac	cardiac	ADJ
ajlm-23	19	28	troponin	troponin	PROPN
ajlm-23	19	29	t	t	PROPN
ajlm-23	19	30	quantitative	quantitative	ADJ
ajlm-23	19	31	reader	reader	NOUN
ajlm-23	19	32	,	,	PUNCT
ajlm-23	19	33	roche	roche	NOUN
ajlm-23	19	34	diagnostics	diagnostic	NOUN
ajlm-23	19	35	;	;	PUNCT
ajlm-23	19	36	figure	figure	NOUN
ajlm-23	19	37	1	1	NUM
ajlm-23	19	38	)	)	PUNCT
ajlm-23	19	39	.	.	PUNCT
ajlm-23	20	1	as	as	SCONJ
ajlm-23	20	2	the	the	DET
ajlm-23	20	3	creatinine	creatinine	NOUN
ajlm-23	20	4	kinase	kinase	PROPN
ajlm-23	20	5	level	level	NOUN
ajlm-23	20	6	was	be	AUX
ajlm-23	20	7	within	within	ADP
ajlm-23	20	8	normal	normal	ADJ
ajlm-23	20	9	limits	limit	NOUN
ajlm-23	20	10	(	(	PUNCT
ajlm-23	20	11	26–140	26–140	NUM
ajlm-23	20	12	u	u	NOUN
ajlm-23	20	13	/	/	SYM
ajlm-23	20	14	l	l	NOUN
ajlm-23	20	15	)	)	PUNCT
ajlm-23	20	16	at	at	ADP
ajlm-23	20	17	both	both	DET
ajlm-23	20	18	visits	visit	NOUN
ajlm-23	20	19	and	and	CCONJ
ajlm-23	20	20	the	the	DET
ajlm-23	20	21	myoglobin	myoglobin	NOUN
ajlm-23	20	22	was	be	AUX
ajlm-23	20	23	normal	normal	ADJ
ajlm-23	20	24	(	(	PUNCT
ajlm-23	20	25	7–64	7–64	PROPN
ajlm-23	20	26	ng	ng	PROPN
ajlm-23	20	27	/	/	SYM
ajlm-23	20	28	l	l	NOUN
ajlm-23	20	29	)	)	PUNCT
ajlm-23	20	30	when	when	SCONJ
ajlm-23	20	31	measured	measure	VERB
ajlm-23	20	32	at	at	ADP
ajlm-23	20	33	the	the	DET
ajlm-23	20	34	second	second	ADJ
ajlm-23	20	35	visit	visit	NOUN
ajlm-23	20	36	,	,	PUNCT
ajlm-23	20	37	the	the	DET
ajlm-23	20	38	patient	patient	NOUN
ajlm-23	20	39	was	be	AUX
ajlm-23	20	40	discharged	discharge	VERB
ajlm-23	20	41	with	with	ADP
ajlm-23	20	42	follow	follow	NOUN
ajlm-23	20	43	-	-	PUNCT
ajlm-23	20	44	up	up	NOUN
ajlm-23	20	45	.	.	PUNCT
ajlm-23	21	1	figure	figure	NOUN
ajlm-23	21	2	1	1	NUM
ajlm-23	21	3	:	:	PUNCT
ajlm-23	21	4	absence	absence	NOUN
ajlm-23	21	5	of	of	ADP
ajlm-23	21	6	a	a	DET
ajlm-23	21	7	control	control	NOUN
ajlm-23	21	8	line	line	NOUN
ajlm-23	21	9	on	on	ADP
ajlm-23	21	10	the	the	DET
ajlm-23	21	11	roche	roche	PROPN
ajlm-23	21	12	cardiac	cardiac	PROPN
ajlm-23	21	13	troponin	troponin	PROPN
ajlm-23	21	14	t	t	PROPN
ajlm-23	21	15	quantitative	quantitative	ADJ
ajlm-23	21	16	test	test	NOUN
ajlm-23	21	17	strip	strip	NOUN
ajlm-23	21	18	.	.	PUNCT
ajlm-23	22	1	interference	interference	NOUN
ajlm-23	22	2	experiments	experiment	NOUN
ajlm-23	22	3	antibody	antibody	NOUN
ajlm-23	22	4	interference	interference	NOUN
ajlm-23	22	5	was	be	AUX
ajlm-23	22	6	suspected	suspect	VERB
ajlm-23	22	7	and	and	CCONJ
ajlm-23	22	8	the	the	DET
ajlm-23	22	9	following	follow	VERB
ajlm-23	22	10	investigation	investigation	NOUN
ajlm-23	22	11	was	be	AUX
ajlm-23	22	12	thus	thus	ADV
ajlm-23	22	13	performed	perform	VERB
ajlm-23	22	14	.	.	PUNCT
ajlm-23	23	1	prior	prior	ADJ
ajlm-23	23	2	ethics	ethic	NOUN
ajlm-23	23	3	approval	approval	NOUN
ajlm-23	23	4	was	be	AUX
ajlm-23	23	5	not	not	PART
ajlm-23	23	6	obtained	obtain	VERB
ajlm-23	23	7	as	as	SCONJ
ajlm-23	23	8	the	the	DET
ajlm-23	23	9	investigation	investigation	NOUN
ajlm-23	23	10	would	would	AUX
ajlm-23	23	11	lead	lead	VERB
ajlm-23	23	12	to	to	ADP
ajlm-23	23	13	improvement	improvement	NOUN
ajlm-23	23	14	in	in	ADP
ajlm-23	23	15	this	this	DET
ajlm-23	23	16	patient	patient	NOUN
ajlm-23	23	17	’s	’s	PART
ajlm-23	23	18	management	management	NOUN
ajlm-23	23	19	.	.	PUNCT
ajlm-23	24	1	firstly	firstly	ADV
ajlm-23	24	2	,	,	PUNCT
ajlm-23	24	3	a	a	DET
ajlm-23	24	4	1:1	1:1	NUM
ajlm-23	24	5	mixture	mixture	NOUN
ajlm-23	24	6	of	of	ADP
ajlm-23	24	7	the	the	DET
ajlm-23	24	8	patient	patient	NOUN
ajlm-23	24	9	’s	’s	PART
ajlm-23	24	10	sample	sample	NOUN
ajlm-23	24	11	and	and	CCONJ
ajlm-23	24	12	a	a	DET
ajlm-23	24	13	recently	recently	ADV
ajlm-23	24	14	-	-	PUNCT
ajlm-23	24	15	assayed	assayed	ADJ
ajlm-23	24	16	anonymous	anonymous	ADJ
ajlm-23	24	17	sample	sample	NOUN
ajlm-23	24	18	positive	positive	ADJ
ajlm-23	24	19	for	for	ADP
ajlm-23	24	20	ctnt	ctnt	ADJ
ajlm-23	24	21	(	(	PUNCT
ajlm-23	24	22	both	both	PRON
ajlm-23	24	23	heparinised	heparinise	VERB
ajlm-23	24	24	whole	whole	ADJ
ajlm-23	24	25	bloods	blood	NOUN
ajlm-23	24	26	)	)	PUNCT
ajlm-23	24	27	,	,	PUNCT
ajlm-23	24	28	was	be	AUX
ajlm-23	24	29	assayed	assayed	ADJ
ajlm-23	24	30	for	for	ADP
ajlm-23	24	31	ctnt.5	ctnt.5	PROPN
ajlm-23	24	32	secondly	secondly	ADV
ajlm-23	24	33	,	,	PUNCT
ajlm-23	24	34	patient	patient	ADJ
ajlm-23	24	35	and	and	CCONJ
ajlm-23	24	36	control	control	NOUN
ajlm-23	24	37	plasma	plasma	NOUN
ajlm-23	24	38	samples	sample	NOUN
ajlm-23	24	39	were	be	AUX
ajlm-23	24	40	depleted	deplete	VERB
ajlm-23	24	41	of	of	ADP
ajlm-23	24	42	immunoglobulin	immunoglobulin	NOUN
ajlm-23	24	43	g	g	PROPN
ajlm-23	24	44	(	(	PUNCT
ajlm-23	24	45	igg	igg	PROPN
ajlm-23	24	46	)	)	PUNCT
ajlm-23	24	47	using	use	VERB
ajlm-23	24	48	protein	protein	NOUN
ajlm-23	24	49	a	a	DET
ajlm-23	24	50	-	-	PUNCT
ajlm-23	24	51	affinity	affinity	NOUN
ajlm-23	24	52	chromatography.6	chromatography.6	PROPN
ajlm-23	24	53	these	these	DET
ajlm-23	24	54	samples	sample	NOUN
ajlm-23	24	55	were	be	AUX
ajlm-23	24	56	analysed	analyse	VERB
ajlm-23	24	57	for	for	ADP
ajlm-23	24	58	ctnt	ctnt	NOUN
ajlm-23	24	59	prior	prior	ADV
ajlm-23	24	60	to	to	ADP
ajlm-23	24	61	and	and	CCONJ
ajlm-23	24	62	after	after	ADP
ajlm-23	24	63	igg	igg	PROPN
ajlm-23	24	64	depletion	depletion	NOUN
ajlm-23	24	65	.	.	PUNCT
ajlm-23	25	1	the	the	DET
ajlm-23	25	2	cardiac	cardiac	ADJ
ajlm-23	25	3	troponin	troponin	PROPN
ajlm-23	25	4	t	t	PROPN
ajlm-23	25	5	quantitative	quantitative	ADJ
ajlm-23	25	6	reader	reader	NOUN
ajlm-23	25	7	is	be	AUX
ajlm-23	25	8	a	a	DET
ajlm-23	25	9	lateral	lateral	ADJ
ajlm-23	25	10	flow	flow	NOUN
ajlm-23	25	11	immunoassay	immunoassay	NOUN
ajlm-23	25	12	,	,	PUNCT
ajlm-23	25	13	utilising	utilise	VERB
ajlm-23	25	14	the	the	DET
ajlm-23	25	15	sandwich	sandwich	NOUN
ajlm-23	25	16	principle	principle	NOUN
ajlm-23	25	17	on	on	ADP
ajlm-23	25	18	a	a	DET
ajlm-23	25	19	test	test	NOUN
ajlm-23	25	20	strip	strip	NOUN
ajlm-23	25	21	with	with	ADP
ajlm-23	25	22	two	two	NUM
ajlm-23	25	23	murine	murine	ADJ
ajlm-23	25	24	monoclonal	monoclonal	ADJ
ajlm-23	25	25	anti	anti	ADJ
ajlm-23	25	26	-	-	ADJ
ajlm-23	25	27	ctnt	ctnt	ADJ
ajlm-23	25	28	antibodies.7	antibodies.7	PUNCT
ajlm-23	25	29	thirdly	thirdly	ADV
ajlm-23	25	30	,	,	PUNCT
ajlm-23	25	31	in	in	ADP
ajlm-23	25	32	order	order	NOUN
ajlm-23	25	33	to	to	PART
ajlm-23	25	34	exclude	exclude	VERB
ajlm-23	25	35	the	the	DET
ajlm-23	25	36	presence	presence	NOUN
ajlm-23	25	37	of	of	ADP
ajlm-23	25	38	interfering	interfere	VERB
ajlm-23	25	39	human	human	ADJ
ajlm-23	25	40	anti	anti	ADJ
ajlm-23	25	41	-	-	ADJ
ajlm-23	25	42	mouse	mouse	ADJ
ajlm-23	25	43	antibodies	antibody	NOUN
ajlm-23	25	44	(	(	PUNCT
ajlm-23	25	45	hama	hama	NOUN
ajlm-23	25	46	)	)	PUNCT
ajlm-23	25	47	,	,	PUNCT
ajlm-23	25	48	mouse	mouse	NOUN
ajlm-23	25	49	serum	serum	NOUN
ajlm-23	25	50	was	be	AUX
ajlm-23	25	51	added	add	VERB
ajlm-23	25	52	to	to	ADP
ajlm-23	25	53	the	the	DET
ajlm-23	25	54	patient	patient	ADJ
ajlm-23	25	55	plasma	plasma	NOUN
ajlm-23	25	56	(	(	PUNCT
ajlm-23	25	57	1:4	1:4	NUM
ajlm-23	25	58	)	)	PUNCT
ajlm-23	25	59	and	and	CCONJ
ajlm-23	25	60	the	the	DET
ajlm-23	25	61	mixture	mixture	NOUN
ajlm-23	25	62	was	be	AUX
ajlm-23	25	63	incubated	incubate	VERB
ajlm-23	25	64	for	for	ADP
ajlm-23	25	65	one	one	NUM
ajlm-23	25	66	hour	hour	NOUN
ajlm-23	25	67	at	at	ADP
ajlm-23	25	68	room	room	NOUN
ajlm-23	25	69	temperature	temperature	NOUN
ajlm-23	25	70	,	,	PUNCT
ajlm-23	25	71	following	follow	VERB
ajlm-23	25	72	which	which	PRON
ajlm-23	25	73	the	the	DET
ajlm-23	25	74	ctnt	ctnt	NOUN
ajlm-23	25	75	was	be	AUX
ajlm-23	25	76	measured	measure	VERB
ajlm-23	25	77	.	.	PUNCT
ajlm-23	26	1	lastly	lastly	ADV
ajlm-23	26	2	,	,	PUNCT
ajlm-23	26	3	to	to	PART
ajlm-23	26	4	determine	determine	VERB
ajlm-23	26	5	whether	whether	SCONJ
ajlm-23	26	6	the	the	DET
ajlm-23	26	7	automated	automate	VERB
ajlm-23	26	8	ctnt	ctnt	NOUN
ajlm-23	26	9	assay	assay	VERB
ajlm-23	26	10	on	on	ADP
ajlm-23	26	11	the	the	DET
ajlm-23	26	12	roche	roche	NOUN
ajlm-23	26	13	elecsys	elecsys	PROPN
ajlm-23	26	14	e170	e170	PROPN
ajlm-23	26	15	analyser	analyser	NOUN
ajlm-23	26	16	was	be	AUX
ajlm-23	26	17	subject	subject	ADJ
ajlm-23	26	18	to	to	ADP
ajlm-23	26	19	the	the	DET
ajlm-23	26	20	same	same	ADJ
ajlm-23	26	21	interference	interference	NOUN
ajlm-23	26	22	,	,	PUNCT
ajlm-23	26	23	dilutions	dilution	NOUN
ajlm-23	26	24	of	of	ADP
ajlm-23	26	25	a	a	DET
ajlm-23	26	26	known	know	VERB
ajlm-23	26	27	ctnt	ctnt	ADJ
ajlm-23	26	28	-	-	PUNCT
ajlm-23	26	29	positive	positive	ADJ
ajlm-23	26	30	plasma	plasma	NOUN
ajlm-23	26	31	sample	sample	NOUN
ajlm-23	26	32	mixed	mix	VERB
ajlm-23	26	33	with	with	ADP
ajlm-23	26	34	the	the	DET
ajlm-23	26	35	patient	patient	ADJ
ajlm-23	26	36	plasma	plasma	NOUN
ajlm-23	26	37	were	be	AUX
ajlm-23	26	38	assayed	assayed	ADJ
ajlm-23	26	39	for	for	ADP
ajlm-23	26	40	ctnt	ctnt	NOUN
ajlm-23	26	41	.	.	PUNCT
ajlm-23	27	1	results	result	VERB
ajlm-23	27	2	top	top	ADJ
ajlm-23	27	3	↑	↑	NUM
ajlm-23	27	4	the	the	DET
ajlm-23	27	5	mixture	mixture	NOUN
ajlm-23	27	6	of	of	ADP
ajlm-23	27	7	whole	whole	ADJ
ajlm-23	27	8	blood	blood	NOUN
ajlm-23	27	9	patient	patient	NOUN
ajlm-23	27	10	sample	sample	NOUN
ajlm-23	27	11	and	and	CCONJ
ajlm-23	27	12	a	a	DET
ajlm-23	27	13	ctnt	ctnt	ADJ
ajlm-23	27	14	-	-	PUNCT
ajlm-23	27	15	positive	positive	ADJ
ajlm-23	27	16	specimen	speciman	NOUN
ajlm-23	27	17	inhibited	inhibit	VERB
ajlm-23	27	18	the	the	DET
ajlm-23	27	19	formation	formation	NOUN
ajlm-23	27	20	of	of	ADP
ajlm-23	27	21	the	the	DET
ajlm-23	27	22	control	control	NOUN
ajlm-23	27	23	line	line	NOUN
ajlm-23	27	24	on	on	ADP
ajlm-23	27	25	the	the	DET
ajlm-23	27	26	ctnt	ctnt	ADJ
ajlm-23	27	27	reagent	reagent	ADJ
ajlm-23	27	28	strip	strip	NOUN
ajlm-23	27	29	,	,	PUNCT
ajlm-23	27	30	supporting	support	VERB
ajlm-23	27	31	our	our	PRON
ajlm-23	27	32	suspicion	suspicion	NOUN
ajlm-23	27	33	of	of	ADP
ajlm-23	27	34	an	an	DET
ajlm-23	27	35	interfering	interfere	VERB
ajlm-23	27	36	substance	substance	NOUN
ajlm-23	27	37	.	.	PUNCT
ajlm-23	28	1	whilst	whilst	SCONJ
ajlm-23	28	2	only	only	ADV
ajlm-23	28	3	the	the	DET
ajlm-23	28	4	control	control	NOUN
ajlm-23	28	5	sample	sample	NOUN
ajlm-23	28	6	elicited	elicit	VERB
ajlm-23	28	7	a	a	DET
ajlm-23	28	8	control	control	NOUN
ajlm-23	28	9	line	line	NOUN
ajlm-23	28	10	prior	prior	ADV
ajlm-23	28	11	to	to	ADP
ajlm-23	28	12	igg	igg	PROPN
ajlm-23	28	13	depletion	depletion	NOUN
ajlm-23	28	14	(	(	PUNCT
ajlm-23	28	15	ctnt	ctnt	VERB
ajlm-23	28	16	<	<	X
ajlm-23	28	17	0.03	0.03	NUM
ajlm-23	28	18	ng	ng	PROPN
ajlm-23	28	19	/	/	SYM
ajlm-23	28	20	ml	ml	PROPN
ajlm-23	28	21	)	)	PUNCT
ajlm-23	28	22	,	,	PUNCT
ajlm-23	28	23	both	both	CCONJ
ajlm-23	28	24	the	the	DET
ajlm-23	28	25	patient	patient	ADJ
ajlm-23	28	26	and	and	CCONJ
ajlm-23	28	27	control	control	NOUN
ajlm-23	28	28	samples	sample	NOUN
ajlm-23	28	29	elicited	elicit	VERB
ajlm-23	28	30	control	control	NOUN
ajlm-23	28	31	lines	line	NOUN
ajlm-23	28	32	after	after	ADP
ajlm-23	28	33	igg	igg	PROPN
ajlm-23	28	34	depletion	depletion	NOUN
ajlm-23	28	35	(	(	PUNCT
ajlm-23	28	36	ctnt	ctnt	VERB
ajlm-23	28	37	<	<	X
ajlm-23	28	38	0.03	0.03	NUM
ajlm-23	28	39	ng	ng	PROPN
ajlm-23	28	40	/	/	SYM
ajlm-23	28	41	ml	ml	PROPN
ajlm-23	28	42	)	)	PUNCT
ajlm-23	28	43	,	,	PUNCT
ajlm-23	28	44	suggesting	suggest	VERB
ajlm-23	28	45	that	that	SCONJ
ajlm-23	28	46	igg	igg	PROPN
ajlm-23	28	47	was	be	AUX
ajlm-23	28	48	the	the	DET
ajlm-23	28	49	interfering	interfere	VERB
ajlm-23	28	50	substance	substance	NOUN
ajlm-23	28	51	.	.	PUNCT
ajlm-23	29	1	test	test	NOUN
ajlm-23	29	2	-	-	PUNCT
ajlm-23	29	3	strips	strip	NOUN
ajlm-23	29	4	contain	contain	VERB
ajlm-23	29	5	hama	hama	NOUN
ajlm-23	29	6	-	-	PUNCT
ajlm-23	29	7	blocking	block	VERB
ajlm-23	29	8	antibodies,7	antibodies,7	NOUN
ajlm-23	29	9	but	but	CCONJ
ajlm-23	29	10	despite	despite	SCONJ
ajlm-23	29	11	the	the	DET
ajlm-23	29	12	presence	presence	NOUN
ajlm-23	29	13	of	of	ADP
ajlm-23	29	14	additional	additional	ADJ
ajlm-23	29	15	blocking	block	VERB
ajlm-23	29	16	agent	agent	NOUN
ajlm-23	29	17	(	(	PUNCT
ajlm-23	29	18	mouse	mouse	NOUN
ajlm-23	29	19	serum	serum	NOUN
ajlm-23	29	20	)	)	PUNCT
ajlm-23	29	21	,	,	PUNCT
ajlm-23	29	22	the	the	DET
ajlm-23	29	23	control	control	NOUN
ajlm-23	29	24	line	line	NOUN
ajlm-23	29	25	did	do	AUX
ajlm-23	29	26	not	not	PART
ajlm-23	29	27	develop	develop	VERB
ajlm-23	29	28	,	,	PUNCT
ajlm-23	29	29	which	which	PRON
ajlm-23	29	30	suggested	suggest	VERB
ajlm-23	29	31	strongly	strongly	ADV
ajlm-23	29	32	that	that	SCONJ
ajlm-23	29	33	the	the	DET
ajlm-23	29	34	interfering	interfere	VERB
ajlm-23	29	35	igg	igg	PROPN
ajlm-23	29	36	was	be	AUX
ajlm-23	29	37	not	not	PART
ajlm-23	29	38	an	an	DET
ajlm-23	29	39	hama	hama	NOUN
ajlm-23	29	40	(	(	PUNCT
ajlm-23	29	41	table	table	NOUN
ajlm-23	29	42	1	1	NUM
ajlm-23	29	43	)	)	PUNCT
ajlm-23	29	44	.	.	PUNCT
ajlm-23	30	1	dilutions	dilution	NOUN
ajlm-23	30	2	of	of	ADP
ajlm-23	30	3	a	a	DET
ajlm-23	30	4	known	know	VERB
ajlm-23	30	5	ctnt	ctnt	ADJ
ajlm-23	30	6	-	-	PUNCT
ajlm-23	30	7	positive	positive	ADJ
ajlm-23	30	8	plasma	plasma	NOUN
ajlm-23	30	9	sample	sample	NOUN
ajlm-23	30	10	with	with	ADP
ajlm-23	30	11	the	the	DET
ajlm-23	30	12	patient	patient	NOUN
ajlm-23	30	13	plasma	plasma	NOUN
ajlm-23	30	14	showed	show	VERB
ajlm-23	30	15	a	a	DET
ajlm-23	30	16	linear	linear	ADJ
ajlm-23	30	17	response	response	NOUN
ajlm-23	30	18	when	when	SCONJ
ajlm-23	30	19	assayed	assayed	ADJ
ajlm-23	30	20	for	for	ADP
ajlm-23	30	21	ctnt	ctnt	NOUN
ajlm-23	30	22	on	on	ADP
ajlm-23	30	23	the	the	DET
ajlm-23	30	24	roche	roche	NOUN
ajlm-23	30	25	elecsys	elecsys	VERB
ajlm-23	30	26	e170	e170	PROPN
ajlm-23	30	27	analyser	analyser	NOUN
ajlm-23	30	28	,	,	PUNCT
ajlm-23	30	29	suggesting	suggest	VERB
ajlm-23	30	30	that	that	SCONJ
ajlm-23	30	31	this	this	DET
ajlm-23	30	32	platform	platform	NOUN
ajlm-23	30	33	is	be	AUX
ajlm-23	30	34	not	not	PART
ajlm-23	30	35	subject	subject	ADJ
ajlm-23	30	36	to	to	ADP
ajlm-23	30	37	the	the	DET
ajlm-23	30	38	same	same	ADJ
ajlm-23	30	39	autoantibody	autoantibody	ADJ
ajlm-23	30	40	interference	interference	NOUN
ajlm-23	30	41	.	.	PUNCT
ajlm-23	31	1	table	table	NOUN
ajlm-23	31	2	1	1	NUM
ajlm-23	31	3	:	:	PUNCT
ajlm-23	31	4	cardiac	cardiac	ADJ
ajlm-23	31	5	troponin	troponin	PROPN
ajlm-23	31	6	t	t	PROPN
ajlm-23	31	7	quantitative	quantitative	ADJ
ajlm-23	31	8	test	test	NOUN
ajlm-23	31	9	strip	strip	NOUN
ajlm-23	31	10	performance	performance	NOUN
ajlm-23	31	11	.	.	PUNCT
ajlm-23	32	1	discussion	discussion	NOUN
ajlm-23	32	2	top	top	PROPN
ajlm-23	32	3	↑	↑	PROPN
ajlm-23	32	4	there	there	PRON
ajlm-23	32	5	is	be	VERB
ajlm-23	32	6	increasing	increase	VERB
ajlm-23	32	7	use	use	NOUN
ajlm-23	32	8	of	of	ADP
ajlm-23	32	9	ctn	ctn	NOUN
ajlm-23	32	10	measurement	measurement	NOUN
ajlm-23	32	11	in	in	ADP
ajlm-23	32	12	the	the	DET
ajlm-23	32	13	diagnosis	diagnosis	NOUN
ajlm-23	32	14	of	of	ADP
ajlm-23	32	15	myocardial	myocardial	ADJ
ajlm-23	32	16	injury	injury	NOUN
ajlm-23	32	17	and	and	CCONJ
ajlm-23	32	18	any	any	DET
ajlm-23	32	19	inaccuracy	inaccuracy	NOUN
ajlm-23	32	20	with	with	ADP
ajlm-23	32	21	regard	regard	NOUN
ajlm-23	32	22	to	to	ADP
ajlm-23	32	23	measured	measured	ADJ
ajlm-23	32	24	values	value	NOUN
ajlm-23	32	25	is	be	AUX
ajlm-23	32	26	more	more	ADV
ajlm-23	32	27	likely	likely	ADJ
ajlm-23	32	28	to	to	PART
ajlm-23	32	29	have	have	VERB
ajlm-23	32	30	serious	serious	ADJ
ajlm-23	32	31	clinical	clinical	ADJ
ajlm-23	32	32	impact	impact	NOUN
ajlm-23	32	33	than	than	SCONJ
ajlm-23	32	34	would	would	AUX
ajlm-23	32	35	be	be	AUX
ajlm-23	32	36	the	the	DET
ajlm-23	32	37	case	case	NOUN
ajlm-23	32	38	with	with	ADP
ajlm-23	32	39	immunoassays	immunoassay	NOUN
ajlm-23	32	40	for	for	ADP
ajlm-23	32	41	many	many	ADJ
ajlm-23	32	42	other	other	ADJ
ajlm-23	32	43	analytes	analyte	NOUN
ajlm-23	32	44	.	.	PUNCT
ajlm-23	33	1	several	several	ADJ
ajlm-23	33	2	immunochemical	immunochemical	ADJ
ajlm-23	33	3	interferences	interference	NOUN
ajlm-23	33	4	have	have	AUX
ajlm-23	33	5	been	be	AUX
ajlm-23	33	6	well	well	ADV
ajlm-23	33	7	described	describe	VERB
ajlm-23	33	8	,	,	PUNCT
ajlm-23	33	9	including	include	VERB
ajlm-23	33	10	heterophile	heterophile	NOUN
ajlm-23	33	11	antibodies,8	antibodies,8	PUNCT
ajlm-23	33	12	rheumatoid	rheumatoid	VERB
ajlm-23	33	13	factor9	factor9	NOUN
ajlm-23	33	14	and	and	CCONJ
ajlm-23	33	15	circulating	circulate	VERB
ajlm-23	33	16	troponin	troponin	PROPN
ajlm-23	33	17	autoantibodies.10,11	autoantibodies.10,11	PROPN
ajlm-23	33	18	recent	recent	ADJ
ajlm-23	33	19	studies	study	NOUN
ajlm-23	33	20	have	have	AUX
ajlm-23	33	21	shown	show	VERB
ajlm-23	33	22	that	that	SCONJ
ajlm-23	33	23	15.9	15.9	NUM
ajlm-23	33	24	%	%	NOUN
ajlm-23	33	25	of	of	ADP
ajlm-23	33	26	samples	sample	NOUN
ajlm-23	33	27	from	from	ADP
ajlm-23	33	28	cohorts	cohort	NOUN
ajlm-23	33	29	of	of	ADP
ajlm-23	33	30	normal	normal	ADJ
ajlm-23	33	31	blood	blood	NOUN
ajlm-23	33	32	donors	donor	NOUN
ajlm-23	33	33	were	be	AUX
ajlm-23	33	34	positive	positive	ADJ
ajlm-23	33	35	for	for	ADP
ajlm-23	33	36	autoantibodies	autoantibody	NOUN
ajlm-23	33	37	to	to	ADP
ajlm-23	33	38	troponin	troponin	PROPN
ajlm-23	33	39	t	t	PROPN
ajlm-23	33	40	or	or	CCONJ
ajlm-23	33	41	troponin	troponin	PROPN
ajlm-23	33	42	i	i	PROPN
ajlm-23	33	43	and	and	CCONJ
ajlm-23	33	44	10.9	10.9	NUM
ajlm-23	33	45	%	%	NOUN
ajlm-23	33	46	were	be	AUX
ajlm-23	33	47	positive	positive	ADJ
ajlm-23	33	48	for	for	ADP
ajlm-23	33	49	both.12	both.12	PROPN
ajlm-23	33	50	autoantibody	autoantibody	ADJ
ajlm-23	33	51	–	–	PUNCT
ajlm-23	33	52	antigen	antigen	ADJ
ajlm-23	33	53	macrocomplexes	macrocomplexe	NOUN
ajlm-23	33	54	have	have	AUX
ajlm-23	33	55	been	be	AUX
ajlm-23	33	56	well	well	ADV
ajlm-23	33	57	described	describe	VERB
ajlm-23	33	58	for	for	ADP
ajlm-23	33	59	a	a	DET
ajlm-23	33	60	number	number	NOUN
ajlm-23	33	61	of	of	ADP
ajlm-23	33	62	biomarkers	biomarker	NOUN
ajlm-23	33	63	such	such	ADJ
ajlm-23	33	64	as	as	ADP
ajlm-23	33	65	salivary	salivary	ADJ
ajlm-23	33	66	amylase,13	amylase,13	NOUN
ajlm-23	33	67	creatine	creatine	VERB
ajlm-23	33	68	kinase,14	kinase,14	ADV
ajlm-23	33	69	aspartate	aspartate	PROPN
ajlm-23	33	70	aminotransferase15	aminotransferase15	NOUN
ajlm-23	33	71	and	and	CCONJ
ajlm-23	33	72	lactate	lactate	NOUN
ajlm-23	33	73	dehyrogenase,16	dehyrogenase,16	NOUN
ajlm-23	34	1	but	but	CCONJ
ajlm-23	34	2	there	there	PRON
ajlm-23	34	3	is	be	VERB
ajlm-23	34	4	no	no	DET
ajlm-23	34	5	evidence	evidence	NOUN
ajlm-23	34	6	to	to	PART
ajlm-23	34	7	suggest	suggest	VERB
ajlm-23	34	8	that	that	SCONJ
ajlm-23	34	9	these	these	DET
ajlm-23	34	10	complexes	complex	NOUN
ajlm-23	34	11	contribute	contribute	VERB
ajlm-23	34	12	to	to	ADP
ajlm-23	34	13	a	a	DET
ajlm-23	34	14	pathological	pathological	ADJ
ajlm-23	34	15	process	process	NOUN
ajlm-23	34	16	.	.	PUNCT
ajlm-23	35	1	in	in	ADP
ajlm-23	35	2	contrast	contrast	NOUN
ajlm-23	35	3	,	,	PUNCT
ajlm-23	35	4	ctn	ctn	NOUN
ajlm-23	35	5	autoantibodies	autoantibody	NOUN
ajlm-23	35	6	have	have	AUX
ajlm-23	35	7	been	be	AUX
ajlm-23	35	8	shown	show	VERB
ajlm-23	35	9	to	to	PART
ajlm-23	35	10	contribute	contribute	VERB
ajlm-23	35	11	to	to	ADP
ajlm-23	35	12	the	the	DET
ajlm-23	35	13	progression	progression	NOUN
ajlm-23	35	14	toward	toward	ADP
ajlm-23	35	15	heart	heart	NOUN
ajlm-23	35	16	failure	failure	NOUN
ajlm-23	35	17	in	in	ADP
ajlm-23	35	18	mice	mouse	NOUN
ajlm-23	35	19	and	and	CCONJ
ajlm-23	35	20	a	a	DET
ajlm-23	35	21	similar	similar	ADJ
ajlm-23	35	22	process	process	NOUN
ajlm-23	35	23	may	may	AUX
ajlm-23	35	24	occur	occur	VERB
ajlm-23	35	25	in	in	ADP
ajlm-23	35	26	humans.17	humans.17	NOUN
ajlm-23	35	27	furthermore	furthermore	ADV
ajlm-23	35	28	,	,	PUNCT
ajlm-23	35	29	it	it	PRON
ajlm-23	35	30	has	have	AUX
ajlm-23	35	31	been	be	AUX
ajlm-23	35	32	proposed	propose	VERB
ajlm-23	35	33	that	that	SCONJ
ajlm-23	35	34	the	the	DET
ajlm-23	35	35	reduced	reduced	ADJ
ajlm-23	35	36	clearance	clearance	NOUN
ajlm-23	35	37	of	of	ADP
ajlm-23	35	38	immunoglobulin	immunoglobulin	NOUN
ajlm-23	35	39	–	–	PUNCT
ajlm-23	35	40	cardiac	cardiac	ADJ
ajlm-23	35	41	troponin	troponin	ADJ
ajlm-23	35	42	complexes	complex	NOUN
ajlm-23	35	43	from	from	ADP
ajlm-23	35	44	the	the	DET
ajlm-23	35	45	circulation	circulation	NOUN
ajlm-23	35	46	may	may	AUX
ajlm-23	35	47	result	result	VERB
ajlm-23	35	48	in	in	ADP
ajlm-23	35	49	increased	increase	VERB
ajlm-23	35	50	levels	level	NOUN
ajlm-23	35	51	of	of	ADP
ajlm-23	35	52	measured	measured	ADJ
ajlm-23	35	53	troponins.18	troponins.18	NOUN
ajlm-23	35	54	this	this	DET
ajlm-23	35	55	phenomenon	phenomenon	NOUN
ajlm-23	35	56	does	do	AUX
ajlm-23	35	57	not	not	PART
ajlm-23	35	58	,	,	PUNCT
ajlm-23	35	59	therefore	therefore	ADV
ajlm-23	35	60	,	,	PUNCT
ajlm-23	35	61	represent	represent	VERB
ajlm-23	35	62	assay	assay	NOUN
ajlm-23	35	63	interference	interference	NOUN
ajlm-23	35	64	,	,	PUNCT
ajlm-23	35	65	but	but	CCONJ
ajlm-23	35	66	rather	rather	ADV
ajlm-23	35	67	an	an	DET
ajlm-23	35	68	analytically	analytically	ADV
ajlm-23	35	69	-	-	PUNCT
ajlm-23	35	70	true	true	ADJ
ajlm-23	35	71	result	result	NOUN
ajlm-23	35	72	,	,	PUNCT
ajlm-23	35	73	albeit	albeit	SCONJ
ajlm-23	35	74	misleading	misleading	ADJ
ajlm-23	35	75	.	.	PUNCT
ajlm-23	36	1	this	this	DET
ajlm-23	36	2	study	study	NOUN
ajlm-23	36	3	shows	show	VERB
ajlm-23	36	4	that	that	SCONJ
ajlm-23	36	5	the	the	DET
ajlm-23	36	6	removal	removal	NOUN
ajlm-23	36	7	of	of	ADP
ajlm-23	36	8	igg	igg	PROPN
ajlm-23	36	9	from	from	ADP
ajlm-23	36	10	patient	patient	ADJ
ajlm-23	36	11	serum	serum	NOUN
ajlm-23	36	12	reverses	reverse	VERB
ajlm-23	36	13	the	the	DET
ajlm-23	36	14	ctnt	ctnt	NOUN
ajlm-23	36	15	assay	assay	NOUN
ajlm-23	36	16	failure	failure	NOUN
ajlm-23	36	17	and	and	CCONJ
ajlm-23	36	18	that	that	SCONJ
ajlm-23	36	19	the	the	DET
ajlm-23	36	20	addition	addition	NOUN
ajlm-23	36	21	of	of	ADP
ajlm-23	36	22	mouse	mouse	NOUN
ajlm-23	36	23	serum	serum	NOUN
ajlm-23	36	24	as	as	ADP
ajlm-23	36	25	a	a	DET
ajlm-23	36	26	heterophile	heterophile	ADJ
ajlm-23	36	27	antibody	antibody	NOUN
ajlm-23	36	28	-	-	PUNCT
ajlm-23	36	29	blocking	block	VERB
ajlm-23	36	30	agent	agent	NOUN
ajlm-23	36	31	has	have	VERB
ajlm-23	36	32	no	no	DET
ajlm-23	36	33	effect	effect	NOUN
ajlm-23	36	34	.	.	PUNCT
ajlm-23	37	1	this	this	PRON
ajlm-23	37	2	,	,	PUNCT
ajlm-23	37	3	together	together	ADV
ajlm-23	37	4	with	with	ADP
ajlm-23	37	5	the	the	DET
ajlm-23	37	6	quantifiable	quantifiable	ADJ
ajlm-23	37	7	result	result	NOUN
ajlm-23	37	8	of	of	ADP
ajlm-23	37	9	the	the	DET
ajlm-23	37	10	myoglobin	myoglobin	NOUN
ajlm-23	37	11	assay	assay	PROPN
ajlm-23	37	12	(	(	PUNCT
ajlm-23	37	13	roche	roche	NOUN
ajlm-23	37	14	diagnostics	diagnostic	NOUN
ajlm-23	37	15	)	)	PUNCT
ajlm-23	37	16	,	,	PUNCT
ajlm-23	37	17	which	which	PRON
ajlm-23	37	18	uses	use	VERB
ajlm-23	37	19	the	the	DET
ajlm-23	37	20	same	same	ADJ
ajlm-23	37	21	test	test	NOUN
ajlm-23	37	22	principle	principle	NOUN
ajlm-23	37	23	,	,	PUNCT
ajlm-23	37	24	species	specie	NOUN
ajlm-23	37	25	of	of	ADP
ajlm-23	37	26	monoclonal	monoclonal	NOUN
ajlm-23	37	27	antibody	antibody	NOUN
ajlm-23	37	28	and	and	CCONJ
ajlm-23	37	29	reader	reader	NOUN
ajlm-23	37	30	as	as	ADP
ajlm-23	37	31	the	the	DET
ajlm-23	37	32	ctnt	ctnt	PROPN
ajlm-23	37	33	assay	assay	VERB
ajlm-23	37	34	,	,	PUNCT
ajlm-23	37	35	suggests	suggest	VERB
ajlm-23	37	36	that	that	SCONJ
ajlm-23	37	37	the	the	DET
ajlm-23	37	38	interference	interference	NOUN
ajlm-23	37	39	may	may	AUX
ajlm-23	37	40	not	not	PART
ajlm-23	37	41	be	be	AUX
ajlm-23	37	42	because	because	SCONJ
ajlm-23	37	43	of	of	ADP
ajlm-23	37	44	a	a	DET
ajlm-23	37	45	heterophile	heterophile	ADJ
ajlm-23	37	46	antibody	antibody	NOUN
ajlm-23	37	47	,	,	PUNCT
ajlm-23	37	48	but	but	CCONJ
ajlm-23	37	49	rather	rather	ADV
ajlm-23	37	50	because	because	SCONJ
ajlm-23	37	51	of	of	ADP
ajlm-23	37	52	an	an	DET
ajlm-23	37	53	autoantibody	autoantibody	NOUN
ajlm-23	37	54	to	to	PART
ajlm-23	37	55	ctnt	ctnt	VERB
ajlm-23	37	56	.	.	PUNCT
ajlm-23	38	1	such	such	DET
ajlm-23	38	2	an	an	DET
ajlm-23	38	3	antibody	antibody	NOUN
ajlm-23	38	4	may	may	AUX
ajlm-23	38	5	compete	compete	VERB
ajlm-23	38	6	with	with	ADP
ajlm-23	38	7	the	the	DET
ajlm-23	38	8	mouse	mouse	NOUN
ajlm-23	38	9	anti	anti	ADJ
ajlm-23	38	10	-	-	ADJ
ajlm-23	38	11	ctnt	ctnt	ADJ
ajlm-23	38	12	–	–	PUNCT
ajlm-23	38	13	gold	gold	NOUN
ajlm-23	38	14	complex	complex	NOUN
ajlm-23	38	15	for	for	ADP
ajlm-23	38	16	binding	bind	VERB
ajlm-23	38	17	to	to	ADP
ajlm-23	38	18	immobilised	immobilised	ADJ
ajlm-23	38	19	ctnt	ctnt	NOUN
ajlm-23	38	20	on	on	ADP
ajlm-23	38	21	the	the	DET
ajlm-23	38	22	test	test	NOUN
ajlm-23	38	23	-	-	PUNCT
ajlm-23	38	24	strip	strip	NOUN
ajlm-23	38	25	,	,	PUNCT
ajlm-23	38	26	which	which	PRON
ajlm-23	38	27	normally	normally	ADV
ajlm-23	38	28	serves	serve	VERB
ajlm-23	38	29	as	as	ADP
ajlm-23	38	30	a	a	DET
ajlm-23	38	31	test	test	NOUN
ajlm-23	38	32	control	control	NOUN
ajlm-23	38	33	.	.	PUNCT
ajlm-23	39	1	in	in	ADP
ajlm-23	39	2	the	the	DET
ajlm-23	39	3	case	case	NOUN
ajlm-23	39	4	of	of	ADP
ajlm-23	39	5	the	the	DET
ajlm-23	39	6	myoglobin	myoglobin	NOUN
ajlm-23	39	7	assay	assay	PROPN
ajlm-23	39	8	,	,	PUNCT
ajlm-23	39	9	the	the	DET
ajlm-23	39	10	immobilised	immobilised	ADJ
ajlm-23	39	11	control	control	NOUN
ajlm-23	39	12	antigen	antigen	PROPN
ajlm-23	39	13	(	(	PUNCT
ajlm-23	39	14	myoglobin	myoglobin	NOUN
ajlm-23	39	15	)	)	PUNCT
ajlm-23	39	16	is	be	AUX
ajlm-23	39	17	different	different	ADJ
ajlm-23	39	18	,	,	PUNCT
ajlm-23	39	19	which	which	PRON
ajlm-23	39	20	may	may	AUX
ajlm-23	39	21	explain	explain	VERB
ajlm-23	39	22	why	why	SCONJ
ajlm-23	39	23	it	it	PRON
ajlm-23	39	24	is	be	AUX
ajlm-23	39	25	unaffected	unaffected	ADJ
ajlm-23	39	26	.	.	PUNCT
ajlm-23	40	1	an	an	DET
ajlm-23	40	2	autoantibody	autoantibody	NOUN
ajlm-23	40	3	could	could	AUX
ajlm-23	40	4	also	also	ADV
ajlm-23	40	5	compete	compete	VERB
ajlm-23	40	6	with	with	ADP
ajlm-23	40	7	reagent	reagent	ADJ
ajlm-23	40	8	anti	anti	ADJ
ajlm-23	40	9	-	-	ADJ
ajlm-23	40	10	ctnt	ctnt	ADJ
ajlm-23	40	11	antibodies	antibody	NOUN
ajlm-23	40	12	for	for	ADP
ajlm-23	40	13	binding	bind	VERB
ajlm-23	40	14	sites	site	NOUN
ajlm-23	40	15	,	,	PUNCT
ajlm-23	40	16	thereby	thereby	ADV
ajlm-23	40	17	preventing	prevent	VERB
ajlm-23	40	18	the	the	DET
ajlm-23	40	19	development	development	NOUN
ajlm-23	40	20	of	of	ADP
ajlm-23	40	21	a	a	DET
ajlm-23	40	22	test	test	NOUN
ajlm-23	40	23	line	line	NOUN
ajlm-23	40	24	(	(	PUNCT
ajlm-23	40	25	figure	figure	NOUN
ajlm-23	40	26	2	2	NUM
ajlm-23	40	27	)	)	PUNCT
ajlm-23	40	28	.	.	PUNCT
ajlm-23	41	1	there	there	PRON
ajlm-23	41	2	have	have	AUX
ajlm-23	41	3	been	be	AUX
ajlm-23	41	4	several	several	ADJ
ajlm-23	41	5	reports	report	NOUN
ajlm-23	41	6	of	of	ADP
ajlm-23	41	7	positive	positive	ADJ
ajlm-23	41	8	interference	interference	NOUN
ajlm-23	41	9	in	in	ADP
ajlm-23	41	10	the	the	DET
ajlm-23	41	11	ctnt	ctnt	NOUN
ajlm-23	41	12	assay	assay	NOUN
ajlm-23	41	13	by	by	ADP
ajlm-23	41	14	heterophilic	heterophilic	ADJ
ajlm-23	41	15	antibodies	antibody	NOUN
ajlm-23	41	16	with	with	ADP
ajlm-23	41	17	the	the	DET
ajlm-23	41	18	cardiac	cardiac	ADJ
ajlm-23	41	19	troponin	troponin	PROPN
ajlm-23	41	20	t	t	PROPN
ajlm-23	41	21	quantitative	quantitative	ADJ
ajlm-23	41	22	test7	test7	PROPN
ajlm-23	41	23	and	and	CCONJ
ajlm-23	41	24	the	the	DET
ajlm-23	41	25	elecsys	elecsys	PROPN
ajlm-23	41	26	e1708	e1708	VERB
ajlm-23	41	27	automated	automate	VERB
ajlm-23	41	28	platform	platform	NOUN
ajlm-23	41	29	but	but	CCONJ
ajlm-23	41	30	,	,	PUNCT
ajlm-23	41	31	to	to	ADP
ajlm-23	41	32	the	the	DET
ajlm-23	41	33	best	good	ADJ
ajlm-23	41	34	of	of	ADP
ajlm-23	41	35	our	our	PRON
ajlm-23	41	36	knowledge	knowledge	NOUN
ajlm-23	41	37	,	,	PUNCT
ajlm-23	41	38	this	this	PRON
ajlm-23	41	39	is	be	AUX
ajlm-23	41	40	the	the	DET
ajlm-23	41	41	first	first	ADJ
ajlm-23	41	42	report	report	NOUN
ajlm-23	41	43	of	of	ADP
ajlm-23	41	44	ctnt	ctnt	ADJ
ajlm-23	41	45	assay	assay	NOUN
ajlm-23	41	46	failure	failure	NOUN
ajlm-23	41	47	on	on	ADP
ajlm-23	41	48	the	the	DET
ajlm-23	41	49	former	former	ADJ
ajlm-23	41	50	platform	platform	NOUN
ajlm-23	41	51	.	.	PUNCT
ajlm-23	42	1	we	we	PRON
ajlm-23	42	2	conclude	conclude	VERB
ajlm-23	42	3	that	that	SCONJ
ajlm-23	42	4	the	the	DET
ajlm-23	42	5	failure	failure	NOUN
ajlm-23	42	6	of	of	ADP
ajlm-23	42	7	this	this	DET
ajlm-23	42	8	assay	assay	NOUN
ajlm-23	42	9	is	be	AUX
ajlm-23	42	10	a	a	DET
ajlm-23	42	11	result	result	NOUN
ajlm-23	42	12	of	of	ADP
ajlm-23	42	13	putative	putative	ADJ
ajlm-23	42	14	autoantibodies	autoantibody	NOUN
ajlm-23	42	15	to	to	PART
ajlm-23	42	16	ctnt	ctnt	VERB
ajlm-23	42	17	.	.	PUNCT
ajlm-23	43	1	assay	assay	NOUN
ajlm-23	43	2	failure	failure	NOUN
ajlm-23	43	3	also	also	ADV
ajlm-23	43	4	allowed	allow	VERB
ajlm-23	43	5	for	for	ADP
ajlm-23	43	6	the	the	DET
ajlm-23	43	7	immediate	immediate	ADJ
ajlm-23	43	8	detection	detection	NOUN
ajlm-23	43	9	of	of	ADP
ajlm-23	43	10	potential	potential	ADJ
ajlm-23	43	11	interference	interference	NOUN
ajlm-23	43	12	,	,	PUNCT
ajlm-23	43	13	but	but	CCONJ
ajlm-23	43	14	the	the	DET
ajlm-23	43	15	majority	majority	NOUN
ajlm-23	43	16	of	of	ADP
ajlm-23	43	17	cases	case	NOUN
ajlm-23	43	18	of	of	ADP
ajlm-23	43	19	interference	interference	NOUN
ajlm-23	43	20	remain	remain	VERB
ajlm-23	43	21	undetected	undetected	ADJ
ajlm-23	43	22	at	at	ADP
ajlm-23	43	23	the	the	DET
ajlm-23	43	24	analytical	analytical	ADJ
ajlm-23	43	25	level	level	NOUN
ajlm-23	43	26	.	.	PUNCT
ajlm-23	44	1	it	it	PRON
ajlm-23	44	2	is	be	AUX
ajlm-23	44	3	crucial	crucial	ADJ
ajlm-23	44	4	,	,	PUNCT
ajlm-23	44	5	therefore	therefore	ADV
ajlm-23	44	6	,	,	PUNCT
ajlm-23	44	7	that	that	SCONJ
ajlm-23	44	8	any	any	DET
ajlm-23	44	9	discrepancies	discrepancy	NOUN
ajlm-23	44	10	between	between	ADP
ajlm-23	44	11	results	result	NOUN
ajlm-23	44	12	and	and	CCONJ
ajlm-23	44	13	the	the	DET
ajlm-23	44	14	clinical	clinical	ADJ
ajlm-23	44	15	picture	picture	NOUN
ajlm-23	44	16	be	be	AUX
ajlm-23	44	17	addressed	address	VERB
ajlm-23	44	18	by	by	ADP
ajlm-23	44	19	clinicians	clinician	NOUN
ajlm-23	44	20	with	with	ADP
ajlm-23	44	21	the	the	DET
ajlm-23	44	22	laboratory	laboratory	NOUN
ajlm-23	44	23	,	,	PUNCT
ajlm-23	44	24	to	to	PART
ajlm-23	44	25	avoid	avoid	VERB
ajlm-23	44	26	further	far	ADV
ajlm-23	44	27	potentially	potentially	ADV
ajlm-23	44	28	-	-	PUNCT
ajlm-23	44	29	invasive	invasive	ADJ
ajlm-23	44	30	and	and	CCONJ
ajlm-23	44	31	expensive	expensive	ADJ
ajlm-23	44	32	investigations	investigation	NOUN
ajlm-23	44	33	.	.	PUNCT
ajlm-23	45	1	figure	figure	VERB
ajlm-23	45	2	2	2	NUM
ajlm-23	45	3	:	:	PUNCT
ajlm-23	45	4	possible	possible	ADJ
ajlm-23	45	5	effect	effect	NOUN
ajlm-23	45	6	of	of	ADP
ajlm-23	45	7	blocking	block	VERB
ajlm-23	45	8	human	human	ADJ
ajlm-23	45	9	anti	anti	ADJ
ajlm-23	45	10	-	-	ADJ
ajlm-23	45	11	cardiac	cardiac	ADJ
ajlm-23	45	12	troponin	troponin	PROPN
ajlm-23	45	13	t	t	PROPN
ajlm-23	45	14	antibodies	antibodie	VERB
ajlm-23	45	15	on	on	ADP
ajlm-23	45	16	the	the	DET
ajlm-23	45	17	roche	roche	PROPN
ajlm-23	45	18	cardiac	cardiac	PROPN
ajlm-23	45	19	troponin	troponin	PROPN
ajlm-23	45	20	t	t	PROPN
ajlm-23	45	21	quantitative	quantitative	ADJ
ajlm-23	45	22	lateral	lateral	ADJ
ajlm-23	45	23	flow	flow	NOUN
ajlm-23	45	24	immunoassay	immunoassay	PROPN
ajlm-23	45	25	.	.	PUNCT
ajlm-23	46	1	conclusion	conclusion	VERB
ajlm-23	46	2	top	top	PROPN
ajlm-23	46	3	↑	↑	PROPN
ajlm-23	46	4	a	a	DET
ajlm-23	46	5	case	case	NOUN
ajlm-23	46	6	of	of	ADP
ajlm-23	46	7	assay	assay	ADJ
ajlm-23	46	8	failure	failure	NOUN
ajlm-23	46	9	was	be	AUX
ajlm-23	46	10	detected	detect	VERB
ajlm-23	46	11	in	in	ADP
ajlm-23	46	12	the	the	DET
ajlm-23	46	13	cardiac	cardiac	ADJ
ajlm-23	46	14	troponin	troponin	PROPN
ajlm-23	46	15	t	t	PROPN
ajlm-23	46	16	quantitative	quantitative	ADJ
ajlm-23	46	17	reader	reader	NOUN
ajlm-23	46	18	.	.	PUNCT
ajlm-23	47	1	immunoassays	immunoassay	NOUN
ajlm-23	47	2	are	be	AUX
ajlm-23	47	3	subject	subject	ADJ
ajlm-23	47	4	to	to	ADP
ajlm-23	47	5	interference	interference	NOUN
ajlm-23	47	6	and	and	CCONJ
ajlm-23	47	7	it	it	PRON
ajlm-23	47	8	is	be	AUX
ajlm-23	47	9	important	important	ADJ
ajlm-23	47	10	to	to	PART
ajlm-23	47	11	investigate	investigate	VERB
ajlm-23	47	12	anomalous	anomalous	ADJ
ajlm-23	47	13	results	result	NOUN
ajlm-23	47	14	to	to	PART
ajlm-23	47	15	exclude	exclude	VERB
ajlm-23	47	16	such	such	ADJ
ajlm-23	47	17	assay	assay	NOUN
ajlm-23	47	18	interference	interference	NOUN
ajlm-23	47	19	.	.	PUNCT
ajlm-23	48	1	after	after	ADP
ajlm-23	48	2	removing	remove	VERB
ajlm-23	48	3	igg	igg	PROPN
ajlm-23	48	4	from	from	ADP
ajlm-23	48	5	patient	patient	ADJ
ajlm-23	48	6	serum	serum	NOUN
ajlm-23	48	7	and	and	CCONJ
ajlm-23	48	8	re	re	NOUN
ajlm-23	48	9	-	-	VERB
ajlm-23	48	10	assaying	assay	VERB
ajlm-23	48	11	the	the	DET
ajlm-23	48	12	ctnt	ctnt	NOUN
ajlm-23	48	13	,	,	PUNCT
ajlm-23	48	14	assay	assay	VERB
ajlm-23	48	15	failure	failure	NOUN
ajlm-23	48	16	was	be	AUX
ajlm-23	48	17	found	find	VERB
ajlm-23	48	18	to	to	PART
ajlm-23	48	19	reverse	reverse	VERB
ajlm-23	48	20	.	.	PUNCT
ajlm-23	49	1	this	this	DET
ajlm-23	49	2	case	case	NOUN
ajlm-23	49	3	highlights	highlight	VERB
ajlm-23	49	4	the	the	DET
ajlm-23	49	5	fact	fact	NOUN
ajlm-23	49	6	that	that	SCONJ
ajlm-23	49	7	immunoassay	immunoassay	PROPN
ajlm-23	49	8	interference	interference	NOUN
ajlm-23	49	9	remains	remain	VERB
ajlm-23	49	10	a	a	DET
ajlm-23	49	11	persistent	persistent	ADJ
ajlm-23	49	12	problem	problem	NOUN
ajlm-23	49	13	and	and	CCONJ
ajlm-23	49	14	vigilance	vigilance	NOUN
ajlm-23	49	15	is	be	AUX
ajlm-23	49	16	encouraged	encourage	VERB
ajlm-23	49	17	in	in	ADP
ajlm-23	49	18	order	order	NOUN
ajlm-23	49	19	to	to	PART
ajlm-23	49	20	minimise	minimise	VERB
ajlm-23	49	21	its	its	PRON
ajlm-23	49	22	impact	impact	NOUN
ajlm-23	49	23	.	.	PUNCT
ajlm-23	50	1	furthermore	furthermore	ADV
ajlm-23	50	2	,	,	PUNCT
ajlm-23	50	3	in	in	ADP
ajlm-23	50	4	the	the	DET
ajlm-23	50	5	case	case	NOUN
ajlm-23	50	6	of	of	ADP
ajlm-23	50	7	troponins	troponin	NOUN
ajlm-23	50	8	,	,	PUNCT
ajlm-23	50	9	interference	interference	NOUN
ajlm-23	50	10	may	may	AUX
ajlm-23	50	11	be	be	AUX
ajlm-23	50	12	caused	cause	VERB
ajlm-23	50	13	by	by	ADP
ajlm-23	50	14	circulating	circulate	VERB
ajlm-23	50	15	autoantibodies	autoantibody	NOUN
ajlm-23	50	16	to	to	ADP
ajlm-23	50	17	ctn	ctn	NOUN
ajlm-23	50	18	.	.	PUNCT
ajlm-23	51	1	acknowledgements	acknowledgement	NOUN
ajlm-23	51	2	top	top	ADJ
ajlm-23	51	3	↑	↑	NOUN
ajlm-23	52	1	we	we	PRON
ajlm-23	52	2	thank	thank	VERB
ajlm-23	52	3	noel	noel	PROPN
ajlm-23	52	4	markgraaf	markgraaf	PROPN
ajlm-23	52	5	for	for	ADP
ajlm-23	52	6	mouse	mouse	NOUN
ajlm-23	52	7	serum	serum	NOUN
ajlm-23	52	8	,	,	PUNCT
ajlm-23	52	9	roche	roche	NOUN
ajlm-23	52	10	diagnostics	diagnostic	NOUN
ajlm-23	52	11	for	for	ADP
ajlm-23	52	12	the	the	DET
ajlm-23	52	13	elecsys	elecsys	NOUN
ajlm-23	52	14	e170	e170	PROPN
ajlm-23	52	15	troponin	troponin	PROPN
ajlm-23	52	16	t	t	PROPN
ajlm-23	52	17	assay	assay	NOUN
ajlm-23	52	18	kit	kit	NOUN
ajlm-23	52	19	and	and	CCONJ
ajlm-23	52	20	dr	dr	PROPN
ajlm-23	52	21	judy	judy	PROPN
ajlm-23	52	22	king	king	PROPN
ajlm-23	52	23	for	for	ADP
ajlm-23	52	24	her	her	PRON
ajlm-23	52	25	critical	critical	ADJ
ajlm-23	52	26	appraisal	appraisal	NOUN
ajlm-23	52	27	of	of	ADP
ajlm-23	52	28	the	the	DET
ajlm-23	52	29	manuscript.this	manuscript.this	PROPN
ajlm-23	52	30	work	work	NOUN
ajlm-23	52	31	was	be	AUX
ajlm-23	52	32	submitted	submit	VERB
ajlm-23	52	33	as	as	ADP
ajlm-23	52	34	a	a	DET
ajlm-23	52	35	presentation	presentation	NOUN
ajlm-23	52	36	at	at	ADP
ajlm-23	52	37	the	the	DET
ajlm-23	52	38	federation	federation	PROPN
ajlm-23	52	39	of	of	ADP
ajlm-23	52	40	south	south	ADJ
ajlm-23	52	41	african	african	ADJ
ajlm-23	52	42	pathology	pathology	NOUN
ajlm-23	52	43	societies	society	NOUN
ajlm-23	52	44	50th	50th	ADJ
ajlm-23	52	45	annual	annual	ADJ
ajlm-23	52	46	congress	congress	NOUN
ajlm-23	52	47	,	,	PUNCT
ajlm-23	52	48	september	september	PROPN
ajlm-23	52	49	2010	2010	NUM
ajlm-23	52	50	and	and	CCONJ
ajlm-23	52	51	as	as	ADP
ajlm-23	52	52	a	a	DET
ajlm-23	52	53	poster	poster	NOUN
ajlm-23	52	54	at	at	ADP
ajlm-23	52	55	the	the	DET
ajlm-23	52	56	international	international	PROPN
ajlm-23	52	57	federation	federation	PROPN
ajlm-23	52	58	of	of	ADP
ajlm-23	52	59	clinical	clinical	ADJ
ajlm-23	52	60	chemistry	chemistry	NOUN
ajlm-23	52	61	and	and	CCONJ
ajlm-23	52	62	laboratory	laboratory	NOUN
ajlm-23	52	63	medicine	medicine	NOUN
ajlm-23	52	64	(	(	PUNCT
ajlm-23	52	65	ifcc	ifcc	NOUN
ajlm-23	52	66	)	)	PUNCT
ajlm-23	52	67	worldlab	worldlab	NOUN
ajlm-23	52	68	and	and	CCONJ
ajlm-23	52	69	euromedlab	euromedlab	NOUN
ajlm-23	52	70	congress	congress	PROPN
ajlm-23	52	71	,	,	PUNCT
ajlm-23	52	72	berlin	berlin	PROPN
ajlm-23	52	73	,	,	PUNCT
ajlm-23	52	74	2011	2011	NUM
ajlm-23	52	75	.	.	PUNCT
ajlm-23	53	1	competing	compete	VERB
ajlm-23	53	2	interest	interest	NOUN
ajlm-23	53	3	the	the	DET
ajlm-23	53	4	authors	author	NOUN
ajlm-23	53	5	declare	declare	VERB
ajlm-23	53	6	that	that	SCONJ
ajlm-23	53	7	they	they	PRON
ajlm-23	53	8	have	have	VERB
ajlm-23	53	9	no	no	DET
ajlm-23	53	10	financial	financial	ADJ
ajlm-23	53	11	or	or	CCONJ
ajlm-23	53	12	personal	personal	ADJ
ajlm-23	53	13	relationship(s	relationship(s	NOUN
ajlm-23	53	14	)	)	PUNCT
ajlm-23	53	15	that	that	PRON
ajlm-23	53	16	may	may	AUX
ajlm-23	53	17	have	have	AUX
ajlm-23	53	18	inappropriately	inappropriately	ADV
ajlm-23	53	19	influenced	influence	VERB
ajlm-23	53	20	them	they	PRON
ajlm-23	53	21	in	in	ADP
ajlm-23	53	22	writing	write	VERB
ajlm-23	53	23	this	this	DET
ajlm-23	53	24	article	article	NOUN
ajlm-23	53	25	.	.	PUNCT
ajlm-23	54	1	authors	author	NOUN
ajlm-23	54	2	’	’	PART
ajlm-23	54	3	contributions	contribution	NOUN
ajlm-23	54	4	f.o	f.o	PROPN
ajlm-23	54	5	.	.	PUNCT
ajlm-23	55	1	(	(	PUNCT
ajlm-23	55	2	university	university	NOUN
ajlm-23	55	3	of	of	ADP
ajlm-23	55	4	cape	cape	PROPN
ajlm-23	55	5	town	town	NOUN
ajlm-23	55	6	/	/	SYM
ajlm-23	55	7	nhls	nhls	PROPN
ajlm-23	55	8	)	)	PUNCT
ajlm-23	55	9	initiated	initiate	VERB
ajlm-23	55	10	the	the	DET
ajlm-23	55	11	study	study	NOUN
ajlm-23	55	12	,	,	PUNCT
ajlm-23	55	13	contributed	contribute	VERB
ajlm-23	55	14	to	to	PART
ajlm-23	55	15	project	project	VERB
ajlm-23	55	16	design	design	NOUN
ajlm-23	55	17	and	and	CCONJ
ajlm-23	55	18	critically	critically	ADV
ajlm-23	55	19	revised	revise	VERB
ajlm-23	55	20	the	the	DET
ajlm-23	55	21	manuscript	manuscript	NOUN
ajlm-23	55	22	.	.	PUNCT
ajlm-23	56	1	p.h.f	p.h.f	ADJ
ajlm-23	56	2	.	.	PUNCT
ajlm-23	57	1	(	(	PUNCT
ajlm-23	57	2	university	university	NOUN
ajlm-23	57	3	of	of	ADP
ajlm-23	57	4	cape	cape	PROPN
ajlm-23	57	5	town	town	NOUN
ajlm-23	57	6	/	/	SYM
ajlm-23	57	7	nhls	nhls	PROPN
ajlm-23	57	8	)	)	PUNCT
ajlm-23	57	9	contributed	contribute	VERB
ajlm-23	57	10	to	to	PART
ajlm-23	57	11	study	study	VERB
ajlm-23	57	12	design	design	NOUN
ajlm-23	57	13	,	,	PUNCT
ajlm-23	57	14	performed	perform	VERB
ajlm-23	57	15	the	the	DET
ajlm-23	57	16	experiments	experiment	NOUN
ajlm-23	57	17	and	and	CCONJ
ajlm-23	57	18	wrote	write	VERB
ajlm-23	57	19	the	the	DET
ajlm-23	57	20	manuscript	manuscript	NOUN
ajlm-23	57	21	.	.	PUNCT
ajlm-23	58	1	references	reference	NOUN
ajlm-23	58	2	top	top	VERB
ajlm-23	58	3	↑	↑	PROPN
ajlm-23	58	4	1	1	NUM
ajlm-23	58	5	.	.	PUNCT
ajlm-23	59	1	thygesen	thygesen	PROPN
ajlm-23	59	2	k	k	PROPN
ajlm-23	59	3	,	,	PUNCT
ajlm-23	59	4	alpert	alpert	PROPN
ajlm-23	59	5	js	js	PROPN
ajlm-23	59	6	,	,	PUNCT
ajlm-23	59	7	jaffe	jaffe	PROPN
ajlm-23	59	8	as	as	ADP
ajlm-23	59	9	,	,	PUNCT
ajlm-23	59	10	et	et	PROPN
ajlm-23	59	11	al	al	PROPN
ajlm-23	59	12	.	.	PROPN
ajlm-23	60	1	on	on	ADP
ajlm-23	60	2	behalf	behalf	NOUN
ajlm-23	60	3	of	of	ADP
ajlm-23	60	4	the	the	DET
ajlm-23	60	5	joint	joint	ADJ
ajlm-23	60	6	esc	esc	NOUN
ajlm-23	60	7	/	/	SYM
ajlm-23	60	8	accf	accf	PROPN
ajlm-23	60	9	/	/	SYM
ajlm-23	60	10	aha	aha	NOUN
ajlm-23	60	11	/	/	SYM
ajlm-23	60	12	whf	whf	PROPN
ajlm-23	60	13	task	task	NOUN
ajlm-23	60	14	force	force	NOUN
ajlm-23	60	15	for	for	ADP
ajlm-23	60	16	the	the	DET
ajlm-23	60	17	universal	universal	ADJ
ajlm-23	60	18	definition	definition	NOUN
ajlm-23	60	19	of	of	ADP
ajlm-23	60	20	myocardial	myocardial	ADJ
ajlm-23	60	21	infarction	infarction	NOUN
ajlm-23	60	22	.	.	PUNCT
ajlm-23	61	1	third	third	ADJ
ajlm-23	61	2	universal	universal	ADJ
ajlm-23	61	3	definition	definition	NOUN
ajlm-23	61	4	of	of	ADP
ajlm-23	61	5	myocardial	myocardial	ADJ
ajlm-23	61	6	infarction	infarction	NOUN
ajlm-23	61	7	.	.	PUNCT
ajlm-23	62	1	eur	eur	NOUN
ajlm-23	62	2	heart	heart	NOUN
ajlm-23	62	3	j.	j.	PROPN
ajlm-23	62	4	2012;33:2551–2567	2012;33:2551–2567	NUM
ajlm-23	62	5	.	.	PUNCT
ajlm-23	63	1	http://dx.doi.org/10.1093/eurheartj/ehs184	http://dx.doi.org/10.1093/eurheartj/ehs184	NOUN
ajlm-23	63	2	,	,	PUNCT
ajlm-23	63	3	pmid:22922414	pmid:22922414	NOUN
ajlm-23	63	4	2	2	NUM
ajlm-23	63	5	.	.	X
ajlm-23	63	6	aldous	aldous	PROPN
ajlm-23	63	7	sj	sj	PROPN
ajlm-23	63	8	,	,	PUNCT
ajlm-23	63	9	florkowski	florkowski	NOUN
ajlm-23	63	10	cm	cm	PROPN
ajlm-23	63	11	,	,	PUNCT
ajlm-23	63	12	crozier	crozier	PROPN
ajlm-23	63	13	ig	ig	PROPN
ajlm-23	63	14	,	,	PUNCT
ajlm-23	63	15	et	et	PROPN
ajlm-23	63	16	al	al	PROPN
ajlm-23	63	17	.	.	PROPN
ajlm-23	64	1	high	high	ADJ
ajlm-23	64	2	sensitivity	sensitivity	NOUN
ajlm-23	64	3	troponin	troponin	ADJ
ajlm-23	64	4	outperforms	outperform	NOUN
ajlm-23	64	5	contemporary	contemporary	ADJ
ajlm-23	64	6	assays	assay	NOUN
ajlm-23	64	7	in	in	ADP
ajlm-23	64	8	predicting	predict	VERB
ajlm-23	64	9	major	major	ADJ
ajlm-23	64	10	adverse	adverse	ADJ
ajlm-23	64	11	cardiac	cardiac	ADJ
ajlm-23	64	12	events	event	NOUN
ajlm-23	64	13	up	up	ADP
ajlm-23	64	14	to	to	PART
ajlm-23	64	15	two	two	NUM
ajlm-23	64	16	years	year	NOUN
ajlm-23	64	17	in	in	ADP
ajlm-23	64	18	patients	patient	NOUN
ajlm-23	64	19	with	with	ADP
ajlm-23	64	20	chest	chest	NOUN
ajlm-23	64	21	pain	pain	NOUN
ajlm-23	64	22	.	.	PUNCT
ajlm-23	65	1	ann	ann	PROPN
ajlm-23	65	2	clin	clin	PROPN
ajlm-23	65	3	biochem	biochem	PROPN
ajlm-23	65	4	.	.	PUNCT
ajlm-23	66	1	2011;48(pt	2011;48(pt	ADJ
ajlm-23	66	2	3):249–255	3):249–255	NUM
ajlm-23	66	3	.	.	PUNCT
ajlm-23	66	4	http://dx.doi.org/10.1258/acb.2010.010220	http://dx.doi.org/10.1258/acb.2010.010220	NOUN
ajlm-23	66	5	,	,	PUNCT
ajlm-23	66	6	pmid:21441393	pmid:21441393	VERB
ajlm-23	66	7	3	3	NUM
ajlm-23	66	8	.	.	PUNCT
ajlm-23	67	1	saunders	saunders	PROPN
ajlm-23	67	2	jt	jt	PROPN
ajlm-23	67	3	,	,	PUNCT
ajlm-23	67	4	nambi	nambi	PROPN
ajlm-23	67	5	v	v	PROPN
ajlm-23	67	6	,	,	PUNCT
ajlm-23	67	7	de	de	PROPN
ajlm-23	67	8	lemos	lemos	PROPN
ajlm-23	67	9	ja	ja	PROPN
ajlm-23	67	10	,	,	PUNCT
ajlm-23	67	11	et	et	PROPN
ajlm-23	67	12	al	al	PROPN
ajlm-23	67	13	.	.	PUNCT
ajlm-23	68	1	cardiac	cardiac	PROPN
ajlm-23	68	2	troponin	troponin	PROPN
ajlm-23	68	3	t	t	PROPN
ajlm-23	68	4	measured	measure	VERB
ajlm-23	68	5	by	by	ADP
ajlm-23	68	6	a	a	DET
ajlm-23	68	7	highly	highly	ADV
ajlm-23	68	8	sensitive	sensitive	ADJ
ajlm-23	68	9	assay	assay	NOUN
ajlm-23	68	10	predicts	predict	VERB
ajlm-23	68	11	coronary	coronary	ADJ
ajlm-23	68	12	heart	heart	NOUN
ajlm-23	68	13	disease	disease	NOUN
ajlm-23	68	14	,	,	PUNCT
ajlm-23	68	15	heart	heart	NOUN
ajlm-23	68	16	failure	failure	NOUN
ajlm-23	68	17	,	,	PUNCT
ajlm-23	68	18	and	and	CCONJ
ajlm-23	68	19	mortality	mortality	NOUN
ajlm-23	68	20	in	in	ADP
ajlm-23	68	21	the	the	DET
ajlm-23	68	22	atherosclerosis	atherosclerosis	NOUN
ajlm-23	68	23	risk	risk	NOUN
ajlm-23	68	24	in	in	ADP
ajlm-23	68	25	communities	community	NOUN
ajlm-23	68	26	study	study	NOUN
ajlm-23	68	27	.	.	PUNCT
ajlm-23	69	1	circulation	circulation	NOUN
ajlm-23	69	2	.	.	PUNCT
ajlm-23	70	1	2011;123(13):1367–1376	2011;123(13):1367–1376	X
ajlm-23	70	2	.	.	PUNCT
ajlm-23	71	1	http://dx.doi.org/10.1161/circulationaha.110.005264	http://dx.doi.org/10.1161/circulationaha.110.005264	NOUN
ajlm-23	71	2	,	,	PUNCT
ajlm-23	71	3	pmid:21422391	pmid:21422391	NUM
ajlm-23	71	4	,	,	PUNCT
ajlm-23	71	5	pmcid	pmcid	ADJ
ajlm-23	71	6	:	:	PUNCT
ajlm-23	71	7	pmc3072024	pmc3072024	ADJ
ajlm-23	71	8	4	4	NUM
ajlm-23	71	9	.	.	PUNCT
ajlm-23	72	1	levinson	levinson	PROPN
ajlm-23	72	2	ss	ss	PROPN
ajlm-23	72	3	,	,	PUNCT
ajlm-23	72	4	miller	miller	PROPN
ajlm-23	72	5	jj	jj	PROPN
ajlm-23	72	6	.	.	PROPN
ajlm-23	72	7	towards	towards	ADP
ajlm-23	72	8	a	a	DET
ajlm-23	72	9	better	well	ADJ
ajlm-23	72	10	understanding	understanding	NOUN
ajlm-23	72	11	of	of	ADP
ajlm-23	72	12	heterophile	heterophile	NOUN
ajlm-23	72	13	(	(	PUNCT
ajlm-23	72	14	and	and	CCONJ
ajlm-23	72	15	the	the	DET
ajlm-23	72	16	like	like	ADJ
ajlm-23	72	17	)	)	PUNCT
ajlm-23	72	18	antibody	antibody	NOUN
ajlm-23	72	19	interference	interference	NOUN
ajlm-23	72	20	with	with	ADP
ajlm-23	72	21	modern	modern	ADJ
ajlm-23	72	22	immunoassays	immunoassay	NOUN
ajlm-23	72	23	.	.	PUNCT
ajlm-23	73	1	clin	clin	PROPN
ajlm-23	73	2	chim	chim	PROPN
ajlm-23	73	3	acta	acta	PROPN
ajlm-23	73	4	.	.	PUNCT
ajlm-23	74	1	2002;325(1–2):1–15	2002;325(1–2):1–15	X
ajlm-23	74	2	.	.	PUNCT
ajlm-23	75	1	http://dx.doi.org/10.1016/s0009-8981(02)00275-9	http://dx.doi.org/10.1016/s0009-8981(02)00275-9	PROPN
ajlm-23	75	2	5	5	NUM
ajlm-23	75	3	.	.	X
ajlm-23	76	1	chan	chan	PROPN
ajlm-23	76	2	ao	ao	PROPN
ajlm-23	76	3	,	,	PUNCT
ajlm-23	76	4	chan	chan	PROPN
ajlm-23	76	5	jp	jp	PROPN
ajlm-23	76	6	,	,	PUNCT
ajlm-23	76	7	choi	choi	PROPN
ajlm-23	76	8	kl	kl	PROPN
ajlm-23	76	9	,	,	PUNCT
ajlm-23	76	10	et	et	PROPN
ajlm-23	76	11	al	al	PROPN
ajlm-23	76	12	.	.	PUNCT
ajlm-23	77	1	a	a	DET
ajlm-23	77	2	patient	patient	NOUN
ajlm-23	77	3	with	with	ADP
ajlm-23	77	4	an	an	DET
ajlm-23	77	5	increased	increase	VERB
ajlm-23	77	6	troponin	troponin	ADJ
ajlm-23	77	7	level	level	NOUN
ajlm-23	77	8	without	without	ADP
ajlm-23	77	9	evidence	evidence	NOUN
ajlm-23	77	10	of	of	ADP
ajlm-23	77	11	ischaemic	ischaemic	ADJ
ajlm-23	77	12	cardiac	cardiac	ADJ
ajlm-23	77	13	injury	injury	NOUN
ajlm-23	77	14	.	.	PUNCT
ajlm-23	78	1	hong	hong	PROPN
ajlm-23	78	2	kong	kong	PROPN
ajlm-23	78	3	med	med	PROPN
ajlm-23	78	4	j.	j.	PROPN
ajlm-23	78	5	2004;10(4):277–279	2004;10(4):277–279	NUM
ajlm-23	78	6	.	.	PUNCT
ajlm-23	79	1	pmid:15299174	pmid:15299174	ADP
ajlm-23	79	2	6	6	NUM
ajlm-23	79	3	.	.	PUNCT
ajlm-23	80	1	selby	selby	PROPN
ajlm-23	80	2	c.	c.	PROPN
ajlm-23	80	3	interference	interference	PROPN
ajlm-23	80	4	in	in	ADP
ajlm-23	80	5	immunoassay	immunoassay	PROPN
ajlm-23	80	6	.	.	PUNCT
ajlm-23	81	1	ann	ann	PROPN
ajlm-23	81	2	clin	clin	PROPN
ajlm-23	81	3	biochem	biochem	PROPN
ajlm-23	81	4	.	.	PUNCT
ajlm-23	82	1	1999;36(pt	1999;36(pt	PROPN
ajlm-23	82	2	6):704–721	6):704–721	PROPN
ajlm-23	82	3	.	.	PUNCT
ajlm-23	83	1	pmid:10586307	pmid:10586307	NOUN
ajlm-23	83	2	7	7	NUM
ajlm-23	83	3	.	.	PUNCT
ajlm-23	83	4	white	white	PROPN
ajlm-23	83	5	gh	gh	PROPN
ajlm-23	83	6	,	,	PUNCT
ajlm-23	83	7	tideman	tideman	NOUN
ajlm-23	83	8	pa	pa	PROPN
ajlm-23	83	9	.	.	PROPN
ajlm-23	84	1	heterophilic	heterophilic	ADJ
ajlm-23	84	2	antibody	antibody	NOUN
ajlm-23	84	3	interference	interference	NOUN
ajlm-23	84	4	with	with	ADP
ajlm-23	84	5	cardiac	cardiac	ADJ
ajlm-23	84	6	t	t	PROPN
ajlm-23	84	7	quantitative	quantitative	ADJ
ajlm-23	84	8	rapid	rapid	ADJ
ajlm-23	84	9	assay	assay	NOUN
ajlm-23	85	1	[	[	X
ajlm-23	85	2	letter	letter	NOUN
ajlm-23	85	3	]	]	PUNCT
ajlm-23	85	4	.	.	PUNCT
ajlm-23	86	1	clin	clin	PROPN
ajlm-23	86	2	chem	chem	PROPN
ajlm-23	86	3	.	.	PUNCT
ajlm-23	87	1	2002;48(1):201–202	2002;48(1):201–202	PROPN
ajlm-23	87	2	.	.	PUNCT
ajlm-23	87	3	pmid:11751561	pmid:11751561	PROPN
ajlm-23	87	4	8	8	NUM
ajlm-23	87	5	.	.	PUNCT
ajlm-23	87	6	shayanfar	shayanfar	PROPN
ajlm-23	87	7	n	n	CCONJ
ajlm-23	87	8	,	,	PUNCT
ajlm-23	87	9	bestmann	bestmann	PROPN
ajlm-23	87	10	l	l	NOUN
ajlm-23	87	11	,	,	PUNCT
ajlm-23	87	12	schulthess	schulthess	VERB
ajlm-23	87	13	g	g	NOUN
ajlm-23	87	14	,	,	PUNCT
ajlm-23	87	15	et	et	PROPN
ajlm-23	87	16	al	al	PROPN
ajlm-23	87	17	.	.	PUNCT
ajlm-23	88	1	false	false	ADJ
ajlm-23	88	2	-	-	PUNCT
ajlm-23	88	3	positive	positive	ADJ
ajlm-23	88	4	cardiac	cardiac	ADJ
ajlm-23	88	5	troponin	troponin	PROPN
ajlm-23	88	6	t	t	PROPN
ajlm-23	88	7	due	due	ADP
ajlm-23	88	8	to	to	PART
ajlm-23	88	9	assay	assay	VERB
ajlm-23	88	10	interference	interference	NOUN
ajlm-23	88	11	with	with	ADP
ajlm-23	88	12	heterophilic	heterophilic	ADJ
ajlm-23	88	13	antibodies	antibody	NOUN
ajlm-23	89	1	[	[	X
ajlm-23	89	2	letter	letter	NOUN
ajlm-23	89	3	]	]	PUNCT
ajlm-23	89	4	.	.	PUNCT
ajlm-23	90	1	swiss	swiss	ADJ
ajlm-23	90	2	med	med	ADJ
ajlm-23	90	3	wkly	wkly	ADV
ajlm-23	90	4	.	.	PUNCT
ajlm-23	91	1	2008;138(31–32):470	2008;138(31–32):470	X
ajlm-23	91	2	.	.	PUNCT
ajlm-23	92	1	pmid:18690561	pmid:18690561	NOUN
ajlm-23	93	1	9	9	NUM
ajlm-23	93	2	.	.	X
ajlm-23	93	3	onuska	onuska	PROPN
ajlm-23	93	4	kd	kd	PROPN
ajlm-23	93	5	,	,	PUNCT
ajlm-23	93	6	hill	hill	PROPN
ajlm-23	93	7	sa	sa	PROPN
ajlm-23	93	8	.	.	PUNCT
ajlm-23	94	1	effect	effect	NOUN
ajlm-23	94	2	of	of	ADP
ajlm-23	94	3	rheumatoid	rheumatoid	NOUN
ajlm-23	94	4	factor	factor	NOUN
ajlm-23	94	5	on	on	ADP
ajlm-23	94	6	cardiac	cardiac	ADJ
ajlm-23	94	7	troponin	troponin	PROPN
ajlm-23	95	1	i	i	PRON
ajlm-23	95	2	measurement	measurement	NOUN
ajlm-23	95	3	using	use	VERB
ajlm-23	95	4	two	two	NUM
ajlm-23	95	5	commercial	commercial	ADJ
ajlm-23	95	6	measurement	measurement	NOUN
ajlm-23	95	7	systems	system	NOUN
ajlm-23	95	8	[	[	X
ajlm-23	95	9	letter	letter	NOUN
ajlm-23	95	10	]	]	PUNCT
ajlm-23	95	11	.	.	PUNCT
ajlm-23	96	1	clin	clin	PROPN
ajlm-23	96	2	chem	chem	PROPN
ajlm-23	96	3	.	.	PUNCT
ajlm-23	97	1	2000;46(2):307–308	2000;46(2):307–308	X
ajlm-23	97	2	.	.	PUNCT
ajlm-23	98	1	pmid:10657400	pmid:10657400	PROPN
ajlm-23	98	2	10	10	NUM
ajlm-23	98	3	.	.	PUNCT
ajlm-23	98	4	bohner	bohner	PROPN
ajlm-23	98	5	j	j	PROPN
ajlm-23	98	6	,	,	PUNCT
ajlm-23	98	7	von	von	PROPN
ajlm-23	98	8	pape	pape	PROPN
ajlm-23	98	9	kw	kw	PROPN
ajlm-23	98	10	,	,	PUNCT
ajlm-23	98	11	hannes	hannes	PROPN
ajlm-23	98	12	w	w	PROPN
ajlm-23	98	13	,	,	PUNCT
ajlm-23	98	14	et	et	PROPN
ajlm-23	98	15	al	al	PROPN
ajlm-23	98	16	.	.	PUNCT
ajlm-23	99	1	false	false	ADJ
ajlm-23	99	2	-	-	PUNCT
ajlm-23	99	3	negative	negative	ADJ
ajlm-23	99	4	immunoassay	immunoassay	ADJ
ajlm-23	99	5	results	result	NOUN
ajlm-23	99	6	for	for	ADP
ajlm-23	99	7	cardiac	cardiac	ADJ
ajlm-23	99	8	troponin	troponin	NOUN
ajlm-23	100	1	i	i	PRON
ajlm-23	100	2	probably	probably	ADV
ajlm-23	100	3	due	due	ADJ
ajlm-23	100	4	to	to	ADP
ajlm-23	100	5	circulating	circulate	VERB
ajlm-23	100	6	troponin	troponin	ADJ
ajlm-23	100	7	i	i	PRON
ajlm-23	100	8	autoantibodies	autoantibody	NOUN
ajlm-23	101	1	[	[	X
ajlm-23	101	2	letter	letter	NOUN
ajlm-23	101	3	]	]	PUNCT
ajlm-23	101	4	.	.	PUNCT
ajlm-23	102	1	clin	clin	PROPN
ajlm-23	102	2	chem	chem	PROPN
ajlm-23	102	3	.	.	PUNCT
ajlm-23	103	1	1996;42(12):2046	1996;42(12):2046	X
ajlm-23	103	2	.	.	PUNCT
ajlm-23	104	1	pmid:8969651	pmid:8969651	NOUN
ajlm-23	104	2	11	11	NUM
ajlm-23	104	3	.	.	PUNCT
ajlm-23	105	1	legendre	legendre	NOUN
ajlm-23	105	2	-	-	PUNCT
ajlm-23	105	3	bazydlo	bazydlo	PROPN
ajlm-23	105	4	la	la	PROPN
ajlm-23	105	5	,	,	PUNCT
ajlm-23	105	6	haverstick	haverstick	VERB
ajlm-23	105	7	dm	dm	PROPN
ajlm-23	105	8	,	,	PUNCT
ajlm-23	105	9	kennedy	kennedy	PROPN
ajlm-23	105	10	jl	jl	PROPN
ajlm-23	105	11	,	,	PUNCT
ajlm-23	105	12	et	et	PROPN
ajlm-23	105	13	al	al	PROPN
ajlm-23	105	14	.	.	PUNCT
ajlm-23	105	15	persistent	persistent	ADJ
ajlm-23	105	16	increase	increase	NOUN
ajlm-23	105	17	of	of	ADP
ajlm-23	105	18	cardiac	cardiac	ADJ
ajlm-23	105	19	troponin	troponin	ADJ
ajlm-23	105	20	i	i	PRON
ajlm-23	105	21	in	in	ADP
ajlm-23	105	22	plasma	plasma	NOUN
ajlm-23	105	23	without	without	ADP
ajlm-23	105	24	evidence	evidence	NOUN
ajlm-23	105	25	of	of	ADP
ajlm-23	105	26	cardiac	cardiac	ADJ
ajlm-23	105	27	injury	injury	NOUN
ajlm-23	105	28	.	.	PUNCT
ajlm-23	106	1	clin	clin	PROPN
ajlm-23	106	2	chem	chem	PROPN
ajlm-23	106	3	.	.	PUNCT
ajlm-23	107	1	2010;56(5):702–705	2010;56(5):702–705	NUM
ajlm-23	107	2	.	.	PUNCT
ajlm-23	108	1	http://dx.doi.org/10.1373/clinchem.2009.138164	http://dx.doi.org/10.1373/clinchem.2009.138164	NOUN
ajlm-23	108	2	,	,	PUNCT
ajlm-23	108	3	pmid:20427735	pmid:20427735	VERB
ajlm-23	108	4	12	12	NUM
ajlm-23	108	5	.	.	PUNCT
ajlm-23	109	1	adamczyk	adamczyk	PROPN
ajlm-23	109	2	m	m	PROPN
ajlm-23	109	3	,	,	PUNCT
ajlm-23	109	4	brashear	brashear	PROPN
ajlm-23	109	5	rj	rj	PROPN
ajlm-23	109	6	,	,	PUNCT
ajlm-23	109	7	mattingly	mattingly	PROPN
ajlm-23	109	8	pg	pg	VERB
ajlm-23	109	9	.	.	PUNCT
ajlm-23	110	1	coprevalence	coprevalence	NOUN
ajlm-23	110	2	of	of	ADP
ajlm-23	110	3	autoantibodies	autoantibody	NOUN
ajlm-23	110	4	to	to	ADP
ajlm-23	110	5	cardiac	cardiac	ADJ
ajlm-23	110	6	troponin	troponin	ADJ
ajlm-23	111	1	i	i	PROPN
ajlm-23	111	2	and	and	CCONJ
ajlm-23	111	3	t	t	PROPN
ajlm-23	111	4	in	in	ADP
ajlm-23	111	5	normal	normal	ADJ
ajlm-23	111	6	blood	blood	NOUN
ajlm-23	111	7	donors	donor	NOUN
ajlm-23	111	8	[	[	X
ajlm-23	111	9	letter	letter	NOUN
ajlm-23	111	10	]	]	PUNCT
ajlm-23	111	11	.	.	PUNCT
ajlm-23	112	1	clin	clin	PROPN
ajlm-23	112	2	chem	chem	PROPN
ajlm-23	112	3	.	.	PUNCT
ajlm-23	113	1	2010;56(4):676–677	2010;56(4):676–677	PROPN
ajlm-23	113	2	.	.	PUNCT
ajlm-23	113	3	http://dx.doi.org/10.1373/clinchem.2009.138099	http://dx.doi.org/10.1373/clinchem.2009.138099	PROPN
ajlm-23	113	4	,	,	PUNCT
ajlm-23	113	5	pmid:20093555	pmid:20093555	ADP
ajlm-23	113	6	13	13	NUM
ajlm-23	113	7	.	.	PUNCT
ajlm-23	114	1	berk	berk	PROPN
ajlm-23	114	2	je	je	PROPN
ajlm-23	114	3	,	,	PUNCT
ajlm-23	114	4	kizu	kizu	PROPN
ajlm-23	114	5	h	h	PROPN
ajlm-23	114	6	,	,	PUNCT
ajlm-23	114	7	wilding	wilde	VERB
ajlm-23	114	8	p	p	PRON
ajlm-23	114	9	,	,	PUNCT
ajlm-23	114	10	et	et	PROPN
ajlm-23	114	11	al	al	PROPN
ajlm-23	114	12	.	.	PROPN
ajlm-23	114	13	macroamylasemia	macroamylasemia	PROPN
ajlm-23	114	14	:	:	PUNCT
ajlm-23	114	15	a	a	DET
ajlm-23	114	16	newly	newly	ADV
ajlm-23	114	17	recognized	recognize	VERB
ajlm-23	114	18	cause	cause	NOUN
ajlm-23	114	19	for	for	ADP
ajlm-23	114	20	elevated	elevated	ADJ
ajlm-23	114	21	serum	serum	NOUN
ajlm-23	114	22	amylase	amylase	NOUN
ajlm-23	114	23	activity	activity	NOUN
ajlm-23	114	24	.	.	PUNCT
ajlm-23	115	1	n	n	PROPN
ajlm-23	115	2	engl	engl	PROPN
ajlm-23	115	3	j	j	PROPN
ajlm-23	115	4	med	med	PROPN
ajlm-23	115	5	.	.	PUNCT
ajlm-23	116	1	1967;277(18):941–946	1967;277(18):941–946	NUM
ajlm-23	116	2	.	.	PUNCT
ajlm-23	116	3	http://dx.doi.org/10.1056/nejm196711022771801	http://dx.doi.org/10.1056/nejm196711022771801	NOUN
ajlm-23	116	4	,	,	PUNCT
ajlm-23	116	5	pmid:4167531	pmid:4167531	VERB
ajlm-23	116	6	14	14	NUM
ajlm-23	116	7	.	.	PUNCT
ajlm-23	117	1	lee	lee	PROPN
ajlm-23	117	2	kn	kn	PROPN
ajlm-23	117	3	,	,	PUNCT
ajlm-23	117	4	csako	csako	PROPN
ajlm-23	117	5	g	g	PROPN
ajlm-23	117	6	,	,	PUNCT
ajlm-23	117	7	bernhardt	bernhardt	PROPN
ajlm-23	117	8	p	p	PROPN
ajlm-23	117	9	,	,	PUNCT
ajlm-23	117	10	et	et	PROPN
ajlm-23	117	11	al	al	PROPN
ajlm-23	117	12	.	.	PUNCT
ajlm-23	117	13	relevance	relevance	NOUN
ajlm-23	117	14	of	of	ADP
ajlm-23	117	15	macro	macro	ADJ
ajlm-23	117	16	creatine	creatine	PROPN
ajlm-23	117	17	kinase	kinase	PROPN
ajlm-23	117	18	type	type	PROPN
ajlm-23	117	19	1	1	NUM
ajlm-23	117	20	and	and	CCONJ
ajlm-23	117	21	type	type	NOUN
ajlm-23	117	22	2	2	NUM
ajlm-23	117	23	isoenzymes	isoenzyme	NOUN
ajlm-23	117	24	to	to	ADP
ajlm-23	117	25	laboratory	laboratory	NOUN
ajlm-23	117	26	and	and	CCONJ
ajlm-23	117	27	clinical	clinical	ADJ
ajlm-23	117	28	data	datum	NOUN
ajlm-23	117	29	.	.	PUNCT
ajlm-23	118	1	clin	clin	PROPN
ajlm-23	118	2	chem	chem	PROPN
ajlm-23	118	3	.	.	PUNCT
ajlm-23	119	1	1994;40(7	1994;40(7	NUM
ajlm-23	119	2	pt	pt	NOUN
ajlm-23	119	3	1):1278–1283	1):1278–1283	PROPN
ajlm-23	119	4	.	.	PUNCT
ajlm-23	120	1	pmid:8013099	pmid:8013099	VERB
ajlm-23	120	2	15	15	NUM
ajlm-23	120	3	.	.	PUNCT
ajlm-23	121	1	krishnamurthy	krishnamurthy	PROPN
ajlm-23	121	2	s	s	PROPN
ajlm-23	121	3	,	,	PUNCT
ajlm-23	121	4	korenblat	korenblat	ADJ
ajlm-23	121	5	km	km	NOUN
ajlm-23	121	6	,	,	PUNCT
ajlm-23	121	7	scott	scott	PROPN
ajlm-23	121	8	mg	mg	PROPN
ajlm-23	121	9	.	.	PUNCT
ajlm-23	122	1	persistent	persistent	ADJ
ajlm-23	122	2	increase	increase	NOUN
ajlm-23	122	3	in	in	ADP
ajlm-23	122	4	aspartate	aspartate	NOUN
ajlm-23	122	5	aminotransferase	aminotransferase	NOUN
ajlm-23	122	6	in	in	ADP
ajlm-23	122	7	an	an	DET
ajlm-23	122	8	asymptomatic	asymptomatic	ADJ
ajlm-23	122	9	patient	patient	NOUN
ajlm-23	122	10	.	.	PUNCT
ajlm-23	123	1	clin	clin	PROPN
ajlm-23	123	2	chem	chem	PROPN
ajlm-23	123	3	.	.	PUNCT
ajlm-23	124	1	2009;55(8):1573–1575	2009;55(8):1573–1575	PROPN
ajlm-23	124	2	.	.	PUNCT
ajlm-23	125	1	http://dx.doi.org/10.1373/clinchem.2008.120782	http://dx.doi.org/10.1373/clinchem.2008.120782	PROPN
ajlm-23	125	2	,	,	PUNCT
ajlm-23	125	3	pmid:19638492	pmid:19638492	PROPN
ajlm-23	125	4	16	16	NUM
ajlm-23	125	5	.	.	PUNCT
ajlm-23	126	1	fujita	fujita	PROPN
ajlm-23	126	2	k	k	PROPN
ajlm-23	126	3	,	,	PUNCT
ajlm-23	126	4	takeya	takeya	VERB
ajlm-23	126	5	c	c	PROPN
ajlm-23	126	6	,	,	PUNCT
ajlm-23	126	7	saito	saito	PROPN
ajlm-23	126	8	t	t	PROPN
ajlm-23	126	9	,	,	PUNCT
ajlm-23	126	10	et	et	PROPN
ajlm-23	126	11	al	al	PROPN
ajlm-23	126	12	.	.	PROPN
ajlm-23	126	13	macro	macro	PROPN
ajlm-23	126	14	lactate	lactate	PROPN
ajlm-23	126	15	dehydrogenase	dehydrogenase	PROPN
ajlm-23	126	16	:	:	PUNCT
ajlm-23	126	17	an	an	DET
ajlm-23	126	18	ldh	ldh	PROPN
ajlm-23	126	19	–	–	PUNCT
ajlm-23	126	20	immunoglobulin	immunoglobulin	NOUN
ajlm-23	126	21	m	m	NOUN
ajlm-23	126	22	complex	complex	NOUN
ajlm-23	126	23	that	that	PRON
ajlm-23	126	24	inhibits	inhibit	VERB
ajlm-23	126	25	lactate	lactate	NOUN
ajlm-23	126	26	dehydrogenase	dehydrogenase	NOUN
ajlm-23	126	27	activity	activity	NOUN
ajlm-23	126	28	in	in	ADP
ajlm-23	126	29	a	a	DET
ajlm-23	126	30	patient	patient	NOUN
ajlm-23	126	31	’s	’s	PART
ajlm-23	126	32	serum	serum	NOUN
ajlm-23	126	33	.	.	PUNCT
ajlm-23	127	1	clin	clin	PROPN
ajlm-23	127	2	chim	chim	PROPN
ajlm-23	127	3	acta	acta	PROPN
ajlm-23	127	4	.	.	PUNCT
ajlm-23	128	1	1984;140(2):183–195	1984;140(2):183–195	NUM
ajlm-23	128	2	.	.	PROPN
ajlm-23	129	1	http://dx.doi.org/10.1016/0009-8981(84)90343-7	http://dx.doi.org/10.1016/0009-8981(84)90343-7	PROPN
ajlm-23	129	2	17	17	NUM
ajlm-23	129	3	.	.	PUNCT
ajlm-23	130	1	wu	wu	PROPN
ajlm-23	130	2	ah	ah	INTJ
ajlm-23	130	3	.	.	PUNCT
ajlm-23	131	1	cardiac	cardiac	ADJ
ajlm-23	131	2	troponin	troponin	ADJ
ajlm-23	131	3	:	:	PUNCT
ajlm-23	131	4	friend	friend	NOUN
ajlm-23	131	5	of	of	ADP
ajlm-23	131	6	the	the	DET
ajlm-23	131	7	cardiac	cardiac	ADJ
ajlm-23	131	8	physician	physician	NOUN
ajlm-23	131	9	,	,	PUNCT
ajlm-23	131	10	foe	foe	NOUN
ajlm-23	131	11	to	to	ADP
ajlm-23	131	12	the	the	DET
ajlm-23	131	13	cardiac	cardiac	ADJ
ajlm-23	131	14	patient	patient	NOUN
ajlm-23	131	15	?	?	PUNCT
ajlm-23	132	1	circulation	circulation	NOUN
ajlm-23	132	2	.	.	PUNCT
ajlm-23	133	1	2006;114(16):1673–1675	2006;114(16):1673–1675	NUM
ajlm-23	133	2	.	.	PUNCT
ajlm-23	133	3	http://dx.doi.org/10.1161/circulationaha.106.652123	http://dx.doi.org/10.1161/circulationaha.106.652123	NOUN
ajlm-23	133	4	,	,	PUNCT
ajlm-23	133	5	pmid:17043176	pmid:17043176	NOUN
ajlm-23	133	6	18	18	NUM
ajlm-23	133	7	.	.	PUNCT
ajlm-23	134	1	pettersson	pettersson	PROPN
ajlm-23	134	2	k	k	PROPN
ajlm-23	134	3	,	,	PUNCT
ajlm-23	134	4	eriksson	eriksson	PROPN
ajlm-23	134	5	s	s	PROPN
ajlm-23	134	6	,	,	PUNCT
ajlm-23	134	7	wittfooth	wittfooth	PROPN
ajlm-23	134	8	s	s	PROPN
ajlm-23	134	9	,	,	PUNCT
ajlm-23	134	10	et	et	PROPN
ajlm-23	134	11	al	al	PROPN
ajlm-23	134	12	.	.	PROPN
ajlm-23	134	13	autoantibodies	autoantibody	NOUN
ajlm-23	134	14	to	to	ADP
ajlm-23	134	15	cardiac	cardiac	ADJ
ajlm-23	134	16	troponin	troponin	ADJ
ajlm-23	134	17	associate	associate	NOUN
ajlm-23	134	18	with	with	ADP
ajlm-23	134	19	higher	high	ADJ
ajlm-23	134	20	initial	initial	ADJ
ajlm-23	134	21	concentrations	concentration	NOUN
ajlm-23	134	22	and	and	CCONJ
ajlm-23	134	23	longer	long	ADJ
ajlm-23	134	24	release	release	NOUN
ajlm-23	134	25	of	of	ADP
ajlm-23	134	26	troponin	troponin	ADJ
ajlm-23	134	27	i	i	PROPN
ajlm-23	134	28	in	in	ADP
ajlm-23	134	29	acute	acute	ADJ
ajlm-23	134	30	coronary	coronary	ADJ
ajlm-23	134	31	syndrome	syndrome	NOUN
ajlm-23	134	32	patients	patient	NOUN
ajlm-23	134	33	.	.	PUNCT
ajlm-23	135	1	clin	clin	PROPN
ajlm-23	135	2	chem	chem	PROPN
ajlm-23	135	3	.	.	PUNCT
ajlm-23	136	1	2009;55(5):938–945	2009;55(5):938–945	X
ajlm-23	136	2	.	.	PUNCT
ajlm-23	137	1	http://dx.doi.org/10.1373/clinchem.2008.115469	http://dx.doi.org/10.1373/clinchem.2008.115469	NOUN
ajlm-23	137	2	,	,	PUNCT
ajlm-23	137	3	pmid:19264856	pmid:19264856	NOUN